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Mycoplasma hyopneumoniae (M. hyopneumoniae) is a prevalent respiratory bacterium 
known to inflict significant health challenges in swine. Opportunities to improve disease 
control efforts exist, as the continuation or reoccurrence of M. hyopneumoniae infection 
occurs. The general objective of this thesis was to provide new information on the 
detection, control, and molecular characterization of this microorganism.  
Insight in the detection and rate of pathogen spread is essential to guide surveillance and 
control efforts. Therefore, the detection and transmission of M. hyopneumoniae were 
evaluated under natural conditions. Bacterial transmission and clinical signs were not 
evident until several weeks after the introduction of one infected pig, highlighting the 
need for accurate surveillance protocols.  
Despite their frequent use for disease control and elimination, there is limited information 
on whether vaccines and antibiotics can alter the spread and persistence of M. 
hyopneumoniae. The effect of multiple vaccinations on M. hyopneumoniae infection and 
transmission was explored. Results indicated that a three-dose vaccination strategy 
against M. hyopneumoniae numerically reduced pathogen transmission, especially when 
the entire population was vaccinated. Next, the effect of medication on M. 
hyopneumoniae transmission and detection by PCR was evaluated during different 
infection phases. Medication numerically reduced the rate of new infections during the 
acute phase of infection. For the chronic phase, persistence of M. hyopneumoniae 
detection by PCR was evident for several months post-treatment. However, the 
infectiousness (or transmission potential) of the bacterium could not be assessed due to 
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lack of transmission. Further research focused on the effect of control measures on M. 
hyopneumoniae transmission is warranted.  
Multiple-Locus Variable number tandem repeat Analysis (MLVA) and complete P146 
gene sequencing were employed to characterize M. hyopneumoniae variants. Fair 
agreement in assay outcome was calculated between the two methods. Discriminatory 
power was higher for MLVA than the P146 sequencing. Nevertheless, similar 
epidemiological inferences were obtained. Using MLVA, genetic diversity of M. 
hyopneumoniae was evaluated across swine production flows. Insight for pathogen origin 
was provided based on the presence of common M. hyopneumoniae variants between 
finishers and the sourcing herds.  
In conclusion, results from this thesis highlight the importance of diagnostics and 
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Mycoplasma hyopneumoniae (M. hyopneumoniae) is one of the most prevalent 
bacterial agents to cause respiratory disease in pigs worldwide and is a primary pathogen 
in the Porcine Respiratory Disease Complex (Pieters and Maes, 2019). Infections with M. 
hyopneumoniae affect herd health and productivity due to the development of a dry 
chronic cough and reduction in growth parameters, which often persists until marketing 
and results in significant economic losses. Moreover, M. hyopneumoniae infections 
predispose pigs to secondary bacterial and viral co-infections through the impairment of 
primary host respiratory defense mechanisms (Debey et al., 1992; Ross 1992), thus 
exacerbating disease challenges and increasing economic losses. The economic impact of 
M. hyopneumoniae has been estimated to be $3.53-7.00 per marketed pig, which can 
equate to $877,375 for a 5,000 breed-to-finish operation per year (Haden et al., 2012; 
Silva et al., 2019).  
Mycoplasma hyopneumoniae is known to spread into susceptible populations via 
the introduction of infected pigs and infectious aerosol particles (Pieters and Maes, 2019). 
The role of contaminated fomites or personnel in the spread of M. hyopneumoniae 
remains unclear, however, it is generally thought to be minor due to short pathogen 
survival times in the environment (Goodwin, 1985; Batista et al., 2004; Browne et al., 
2017). Once M. hyopneumoniae has been established in a herd, endemicity of infection is 
thought to occur through the presence of susceptible subpopulations and their contact 
with respiratory secretions from infected pigs (Fano et al., 2005). Challenges with 
achieving pathogen control are mainly attributed to the slow and persistent nature of M. 
hyopneumoniae infection.  
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Several control measures, like vaccination and medication, are implemented to 
lessen disease severity (Maes et al., 2008), however, little is known about the effect of 
control strategies on M. hyopneumoniae transmission. In recent years, efforts have been 
made to employ long-term measures of pathogen control, namely M. hyopneumoniae 
elimination strategies (Holst et al., 2015), followed by robust biosecurity practices and 
surveillance protocols. However, M. hyopneumoniae outbreaks still occur, thus 
questioning the potential source of pathogen introduction and the efficacy of control, 
elimination, and prevention strategies.  
To aid in M. hyopneumoniae control and elimination efforts, this thesis aims to 
provide new information on the detection, control, and molecular characterization of this 
microorganism. Therefore, the following specific objectives were proposed: a) evaluate 
the detection and transmission of M. hyopneumoniae following natural infections; b) 
assess the effect of control interventions on pathogen detection and transmission; c) 
characterize and compare M. hyopneumoniae variants using different molecular 
techniques to aid future epidemiological investigations and pathogen tracing; and d) 
evaluate genetic diversity of M. hyopneumoniae within production flows to provide 
insight on inter-herd transmission. 
To optimize control and elimination efforts, detecting and accurately measuring 
the rate at which the pathogen can spread in a population is critical, especially under 
conditions that can be extrapolated to the field. From this, sampling protocols can be 
developed to either confirm freedom of disease in a naïve population or surveil for new 
infections. As of today, our knowledge of M. hyopneumoniae transmissibility has been 
based on data generated from clinical samples of limited diagnostic sensitivity (Pieters et 
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al., 2017) under experimental conditions (Meyns et al., 2004; Villarreal et al., 2011a). In 
Chapter 2, the natural transmission and detection of M. hyopneumoniae were evaluated to 
estimate the rate of pathogen spread in a naïve population and to explore the likelihood of 
missing a recent introduction based on clinical samples with high diagnostic sensitivity.   
Improvements in understanding whether control interventions can influence the 
degree of M. hyopneumoniae transmission are warranted. Currently, there is minimal 
information on whether vaccines and antibiotics can affect M. hyopneumoniae 
transmission, and to what extent this occurs. Therefore, opportunities to use control 
interventions in a strategic and effective manner to aid in the reduction M. 
hyopneumoniae transmission in a population exist. In Chapter 3, the effect of multiple 
vaccinations on M. hyopneumoniae infection and transmission rate was assessed using an 
in vivo seeder-to-contact model. Moreover, Chapter 4 explored differences in M. 
hyopneumoniae detection and transmission when acutely and chronically infected pigs 
were treated with a bacteriostatic antibiotic commonly used for the therapeutic and 
metaphylactic treatment of M. hyopneumoniae infection. 
Mycoplasma hyopneumoniae control and biosecurity measures at the herd or 
regional level are supported by the ability to detect and trace pathogen spread. Over the 
years, there has been a growing need to utilize molecular characterization techniques in 
the field to better understand the inter-herd transmission of M. hyopneumoniae or even 
distinguish between elimination failures or new disease introductions.  
In the past decade, the swine industry has shifted its focus to control M. 
hyopneumoniae infection at the sow herd level to influence disease outcome in 
downstream flows proactively, as infected sow herds are considered the reservoir for 
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pathogen origin for downstream grower-finisher pigs. This perception has stemmed from 
our current knowledge in the epidemiology of this bacterium. Research aimed towards 
the application of molecular techniques to epidemiologically link M. hyopneumoniae 
infection between herds is necessary to support this hypothesis. However, there is limited 
knowledge of the interpretation and comparison of molecular characterization techniques 
for M. hyopneumoniae, along with the epidemiological insight gained from the genomic 
analyses. In the United States, there are two commonly employed molecular methods, 
namely, Multiple-Locus Variable number tandem repeat Analysis (MLVA) and the 
complete gene sequencing of the adhesin-like protein, P146. Nevertheless, questions 
surrounding the discriminatory power of these molecular techniques and their ability to 
infer the genetic relatedness between variants currently exists. In Chapter 5, circulating 
M. hyopneumoniae variants in the Midwestern United States were characterized and 
compared using the two commonly employed molecular methods. Based on the findings 
from Chapter 5, MLVA was employed in Chapter 6 to evaluate the genetic diversity of 
M. hyopneumoniae within production flows.  
New knowledge gained from this thesis will allow veterinarians to make informed 
decisions that will improve surveillance, control, and elimination efforts for M. 
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1.1       Mycoplasmas 
Mycoplasmas are a genus of bacteria classified under the class Mollicutes and 
family Mycoplasmataceae, and are known to colonize and affect several species of 
plants, insects, and animals (Razin et al., 1983). Mycoplasmas are recognized as the 
smallest, self-replicating prokaryotes, ranging from 0.2 to 0.8 µm in diameter (Razin et 
al., 1983). Morphologically, Mycoplasma colonies are pleomorphic and resemble a “fried 
egg” in agar, consisting of a central, granular zone embedded in agar and a flat peripheral 
zone on the surface (Razin et al., 1983). Most Mycoplasmas are non-motile; however, 
some species exhibit structures that allow for movement, adhesion, and even penetration 
of host cells (Razin and Jacobs, 1992).  
Through phylogenetic analyses, it has been suggested that Mollicutes have 
evolved by degenerative evolution from Gram-positive eubacteria, allowing for unique 
taxonomic characteristics (Woese et al., 1980; Maniloff, 1992). A distinguishing feature 
that Mycoplasmas exhibit is their lack of a cell wall, making them sensitive to lysis and 
resistant to certain antibiotics, specifically ꞵ-lactams. Moreover, Mycoplasmas have a 
small genome (580 to 1380 kbp) that is composed of low guanine and cytosine (G+C) 
content (24-41 mol%) and utilize TGA (UGA) as a tryptophan codon rather than a stop 
codon (Razin, 1978; Woese et al., 1980). Due to their small genetic composition, 
Mycoplasmas have limited biosynthetic abilities and rely heavily on host nutrients for 
growth (Razin et al., 1998).  
1.2 Swine Mycoplasmas 
In general, Mycoplasmas have been described to be host-specific, commensal 
and/or pathogenic bacteria. For swine, six host-specific Mycoplasmas have been isolated, 
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namely: Mycoplasma hyopneumoniae (M. hyopneumoniae; Goodwin et al., 1965; Maré 
and Switzer, 1965), M. hyorhinis (Switzer, 1955), M. hyosynoviae (Ross and Karmon, 
1970), M. suis (formerly Eperythrozoon suis; Splitter, 1950), M. flocculare (Meyling and 
Friis, 1972) and M. hyopharyngis (Erickson et al., 1986). Among these isolated 
Mycoplasmas,  M. hyopneumoniae, M. hyorhinis, M. hyosynoviae, and M. suis are 
recognized as pathogens of significant importance, while M. flocculare and M. 
hyopharyngis have been described to be either non-pathogenic or have a limited role in 
disease. Pathogen classification and associated diseases for common swine Mycoplasmas 
are provided in Table 1.1.    
1.3  Mycoplasma hyopneumoniae 
Mycoplasma hyopneumoniae is the etiologic agent of enzootic pneumonia in 
swine (Goodwin et al., 1965; Maré and Switzer, 1965) and causes a dry cough and 
reduced weight gain in growing pigs. Early descriptions of a pig respiratory disease were 
reported in Germany during the 1930s and named ‘Ferkelgrippe’ (i.e., ‘Piglet flu’ in 
German; Kӧbe, 1933). However, this disease was described to be different from swine 
Influenza due to the presence of chronic and persistent pneumonia that lasted for several 
weeks, causing a reduction in growth rate and significant, cumulative economic losses 
(Blakemore and Gledhill, 1941; Fulton et al., 1953; Hjärre et al., 1952; Plowright, 1953; 
Rislakki, 1953; Goodwin and Whittlestone, 1963). The disease was later denominated as 
‘infectious pneumonia,’ ‘parainfluenza,’ or ‘virus pneumonia of pigs’ due to the inability 
to isolate Influenza and the slower onset of disease (Gulrajani and Beveridge, 1951; Betts 
and Beveridge, 1952).  At the time, the etiologic agent was misperceived to be a virus as 
the agent could pass through a biological filter, despite its susceptibility to antibiotics 
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(Betts and Beveridge, 1952). Thirty years later, Maré and Switzer (1965) in the United 
States, followed by Goodwin et al. (1965) in the United Kingdom published the isolation 
of this microorganism in solid medium and their ability to reproduce the disease in pigs, 
thus fulfilling Koch’s postulates. They named the microorganism ‘M. hyopneumoniae’ 
and ‘M. suipneumoniae’, respectively. Shortly after, both microorganisms were shown to 
be serologically indistinguishable by growth-inhibition and metabolic-inhibition tests 
(Goodwin et al., 1967; Hodges and Betts, 1969; Takatori, 1970). From then on, the 
former name, M. hyopneumoniae, took precedence.  
1.3.1 Pathogenesis  
While the pathogenesis of M. hyopneumoniae is complex and not yet fully 
understood, disease development is hallmarked by bacterial migration and adherence to 
ciliated respiratory epithelium, impairment of mucociliary apparatus, and modulation of 
innate and adaptive immune responses (Debey et al., 1992; Blanchard et al., 1992; 
reviewed by Pieters and Maes, 2019).  
Colonization with M. hyopneumoniae occurs through the inhalation of bacteria-
containing aerosol droplets, followed by the pathogen’s ability to withstand clearance 
from innate immune defense mechanisms, such as the mucociliary apparatus and 
coughing. After inspiration, M. hyopneumoniae penetrates the mucosal layer and adheres 
to ciliated epithelial cells in the trachea, bronchi, and bronchioles. Adherence is mediated 
through receptor-ligand interactions and surface adhesin proteins (Ross, 1999). Most 
surface proteins are believed to be anchored in the cytoplasmic membrane by 
extracellular milieu and acyl groups (Browning et al., 2011). Cilium adherence has been 
proposed to primarily involve a 97-kDa protein, named P97 (Hsu et al., 1997). Several 
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paralogs of P97, including P146 (mhp 684), P216, P116, and P135, have been involved in 
cilium binding and can undergo posttranslational cleavage (Tacchi et al., 2016; Kuhnert 
and Jores, 2020). Cleaved fragments can bind heparin, plasminogen, and fibronectin and 
facilitate plasmin production, which has been proposed to aid in tissue invasion and 
inflammation (Burnett et al., 2006; Deutscher et al., 2010, Seymour et al., 2010, Seymour 
et al., 2011, Bogema et al., 2012). Following M. hyopneumoniae adherence, ciliostasis, 
deciliation of respiratory epithelium, and depletion of goblet cells occur, resulting in the 
impairment of the mucociliary apparatus (DeBey et al., 1992). Damage of this immune 
defense mechanism reduces the clearance of mucus, debris, and non-host cells, thus 
aiding in the invasion and propagation of secondary respiratory pathogens.   
Recognition of M. hyopneumoniae by the host involves the employment of innate 
pattern-recognition receptors, including Toll-like receptors 2 and 6, which identify 
pathogen lipoproteins and activate signaling pathways, triggering the induction of innate 
immune responses (Lein et al., 1999; Muneta et al., 2003; Summerfield, 2020). As a 
result, pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6, IL-8, and tumor 
necrosis factor-α (TNF-α) are produced from alveolar macrophages and lymphocytes 
(Thacker et al., 2000; Rodriguez et al., 2004), inducing a localized inflammatory 
response and lymphoid hyperplasia in lungs. Moreover, the conversion of plasminogen to 
plasmin contributes to inflammation by stimulating macrophage signaling, resulting in 
reactive oxygen species and cytokine release (Syrovets et al., 2012). In turn, an influx of 
neutrophils and macrophages arises, followed by lymphocyte infiltration in the 
peribronchiolar and surrounding perivascular tissue. Several studies have proposed that 
M. hyopneumoniae infection also results in generalized immunosuppression, through the 
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induction of anti-inflammatory cytokines (i.e., IL-10), alteration of lymphocyte 
transformation, and inhibition of interferon-γ (Kishima and Ross, 1985; 
Thanawongnuwech and Thacker, 2004; Muneta et al., 2006; Muneta et al., 2008). Such 
modulatory effects of the inflammatory response and immune system are the primary 
drivers for enzootic pneumonia lesions. 
1.3.2 Mycoplasma hyopneumoniae infections in the swine industry 
As a primary respiratory disease, M. hyopneumoniae infection results in 
significant health and economic concerns worldwide. Economic losses are primarily 
attributed to increased antibiotic and vaccine usage and other resources (e.g., feed, 
facilities) to offset production losses for the achievement of full-value market pigs.   
Production losses from M. hyopneumoniae infection include a reduction in gain, poor 
feed conversion, increased body weight variation, and increased mortality and culling 
rates. Studies have shown a 2.8-15.9% decrease in daily weight gain, 0.6-13.8% 
reduction in feed conversion, and 1.3-6.0% mortality rate in endemically infected 
growing herds (Pointon et al., 1985; Straw et al., 1989; Silva et al., 2019; Haden et al., 
2012). Moreover, Straw et al. (1990) calculated a 37.4g/day reduction in gain for every 
10% of lung affected with pneumonia. Reductions in growth parameters have been 
described to increase the time to market by up to 30 days, resulting in increased cost per 
pig space and decreased number of turns per year (Noyes et al., 1990). Silva et al. (2019) 
also estimated an increase in antibiotic ($1.20) and vaccination ($0.25) cost per pig, 
resulting in $7.00 per pig marketed, when costs associated with productivity losses were 
included. An economic value of $0.63-$3.53 per finisher pig has been calculated for 
herds solely affected by M. hyopneumoniae and up to $10.12 per pig for herds co-
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infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome 
virus (PRRSv) or Influenza A virus in swine (IAV-S; Haden et al., 2012). Nevertheless, 
the ability to obtain accurate information related to the economic impact of M. 
hyopneumoniae infection is limited and can be challenging to ascertain, especially under 
field conditions, as secondary infections are often present and can also affect production 
and economic parameters.  
Mycoplasma hyopneumoniae is a primary contributor to the Porcine Respiratory 
Disease Complex (PRDC). Impairment of the mucociliary apparatus and immune 
modulation have been identified as key underlying factors that elicit and exacerbate 
diseases associated with M. hyopneumoniae infection and secondary bacterial and viral 
pathogens. Studies have shown M. hyopneumoniae to potentiate disease severity when 
Pasteurella multocida or Actinobacillus pleuropneumoniae infections are present (Marois 
et al., 1989b; Amass et al., 1994; Marois et al., 2009; Eamens et al., 2012). Interaction of 
M. hyopneumoniae with primary viral pathogens, such as PRRSv, IAV-S, or porcine 
circovirus type 2 (PCV-2), often results in synergistic and/or additive effects on disease 
severity, depending on timing and sequence of the infections (Marois-Créhan et al., 
2020). Therefore, a better understanding of the interaction between M. hyopneumoniae 
and other respiratory pathogens is essential to control enzootic pneumonia and PRDC.  
Due to the health concerns and economic losses associated with enzootic 
pneumonia, researchers and veterinarians have strived to optimize the control of M. 
hyopneumoniae by establishing a strong understanding of pathogen-specific 
epidemiology, along with the development and application of accurate and effective 
diagnostic and treatment modalities.   
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1.3.3 Epidemiology  
1.3.3.1 Prevalence  
Mycoplasma hyopneumoniae infection has generally been thought to be 
distributed worldwide. Since this pathogen is non-reportable and difficult to ascertain due 
to clinical and diagnostic limitations, data describing M. hyopneumoniae prevalence in 
the United States or in other countries is either limited or not available. Nonetheless, M. 
hyopneumoniae infection has been historically described in almost every pig producing 
country (Pieters and Maes, 2019). Over the past two decades, national elimination 
programs for M. hyopneumoniae have been conducted in commercial herds and deemed 
successful in Switzerland (Stärk et al., 2007), Norway (Guilliksen et al., 2019), and 
Finland (Rautiainen et al., 2001). In the United States, results generated from a national 
study showed a high prevalence of M. hyopneumoniae in 2012, as 39% and 59% 
surveyed breeding and grow-finish herds (n=2,119), respectively, had reported disease 
challenges attributed to the infection (NAHMS, 2012). Nevertheless, more information 
regarding M. hyopneumoniae prevalence in the United States is warranted to aid in 
understanding disease burden in a geographical location and guide regional and/or 
national surveillance and control programs.   
1.3.3.2 Transmission routes 
Horizontal transmission is considered the main route for M. hyopneumoniae 
infection and occurs via direct contact with respiratory secretions between infected and 
susceptible pigs, regardless of age (Etheridge et al., 1979; Morris et al., 1995). Piglets are 
considered free of M. hyopneumoniae at birth as in-utero transmission has not been 
described, but can be colonized as early as one week of age (Sibila et al., 2007b). 
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Therefore, the transmission of M. hyopneumoniae from dams to corresponding offspring 
has also been considered an essential contributor to piglet colonization (Calsamiglia and 
Pijoan, 2000a) and disease development in downstream herds (Fano et al., 2007). Indirect 
transmission via aerosol plays a role in the spread of M. hyopneumoniae at both the intra- 
and inter-herd level. Aerosol transmission was initially implied as earlier studies showed 
the risk of disease introduction to decrease as the distance from infected herds increased 
(Goodwin, 1985; Jorsal and Thomsen, 1988, Stärk et al., 1992). Concordantly, M. 
hyopneumoniae detection and viability were shown in air samples collected at various 
distances, ranging from 2.3 (Dee et al., 2009) to 9.2 km (Otake et al., 2010) from infected 
herds. Nevertheless, the likelihood of M. hyopneumoniae transmission via aerosol or 
local area spread has been reported to be low as Yeske et al. (2017) showed that 8% of 
flows within areas of high swine herd density became laterally infected with the 
pathogen. Although a low probability of lateral transmission was described, high 
consequences can arise if the site was a M. hyopneumoniae negative gilt developing unit 
or sow herd. From this study, it is important to note that M. hyopneumoniae lateral 
transmission was assessed among finisher herds, which may differ from sow herds. 
Spread of M. hyopneumoniae via contaminated fomites or personnel has been generally 
thought to be of little importance due to short pathogen survival times in the environment 
(Goodwin, 1985; Batista et al., 2004; Browne et al., 2017) and the implementation of 
biosecurity measures (Batista et al., 2004; Pitkin et al., 2011).  
1.3.3.3 Infection dynamics 
In general, M. hyopneumoniae infection is hallmarked by its slow and persistent 
nature and is often divided into two phases: acute and chronic, based on clinical 
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presentation. The acute phase of infection includes the incubation period and a clinical 
period, marked by the onset and cessation of a non-productive cough, whereas the 
chronic phase is characterized by an asymptomatic, carrier state (Ross, 1999; Pieters et 
al., 2009). The duration of M. hyopneumoniae infection can last up to eight months, as 
Pieters et al. (2009) showed that pigs infected with a moderately virulent strain (232; 
Minion et al., 2004) remained PCR positive and transmitted the pathogen for up to 214 
days post-inoculation (dpi), followed by the absence of M. hyopneumoniae detection and 
transmission at 240 dpi. Throughout the course of infection, progression of disease 
processes will occur, thus influencing the timing of clinical signs and diagnostic 
outcomes. Moreover, M. hyopneumoniae strains of different virulence, ranging from 
avirulent, to low and high virulence, have been described (Vicca et al., 2003), which may 
influence the course of infection. A summarized timeline that highlights the infection 
dynamics with regards to a diagnosis using detection of genetic material and antibodies 
for M. hyopneumoniae, under experimental conditions, is illustrated in Figure 1.1.  
Under experimental conditions, the minimum dose to induce M. hyopneumoniae 
infection has been 1x104 color-changing units (CCU)/mL (Marois et al., 2010). Dynamics 
of M. hyopneumoniae infection include a latent period of approximately five days 
(Pieters et al., 2017) and an incubation period of 10 to 16 days (Ross, 1999). A 5-day 
latent period, the period between exposure and onset of infectiousness, has been 
suggested, as negative PCR results have been obtained at 2 dpi in various antemortem 
sample types (Pieters et al., 2017). The incubation period for M. hyopneumoniae, the time 
between exposure to the pathogen and onset of clinical signs, has been estimated from 
experimental studies and may be longer under natural conditions. During this subclinical 
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period, there is a high likelihood of missing a recent disease introduction due to the 
absence of clinical signs, resulting in unforeseen health concerns, and limitations in 
diagnostic sensitivity if accurate surveillance strategies are not implemented. Moreover, 
the transmission of M. hyopneumoniae before the onset of clinical signs has not been 
described. However, this would be important to assess to aid in surveillance and disease 
control efforts. 
During the acute phase of infection, cough frequency and shedding have been 
described to peak around 28 dpi, followed by the cessation of clinical signs at six-to-eight 
weeks after onset (Pieters et al., 2009; Garcia-Morante et al., 2016; Roos et al., 2016). 
Furthermore, the adjusted basic reproductive number has been estimated to be low 
(Rn=0.56-1.16) under experimental and field conditions, implying that 0.56-1.16 
secondary infections per infected pig can occur in a 6-week period (Meyns et al., 2004; 
Villarreal et al., 2011a). At the peak of shedding, Roos et al. (2016) calculated the M. 
hyopneumoniae transmission rate (ꞵ) to be 1.28 new infected gilts/gilt-week during a 
four-week period. It is important to mention that parameters calculated by Roos et al. 
(2016) were higher than previous studies, as transmission was assessed at a time when 
peak of shedding has been suggested. For the chronic phase of infection, epidemiological 
metrics to describe the contagiousness or transmissibility of M. hyopneumoniae have not 
been estimated, mainly due to the limited feasibility of conducting in-vivo experimental 
models given the long shedding duration.  
In the field, the persistence of M. hyopneumoniae infection and presentation of 
clinical signs have been well documented. Clinical signs are predominately evident 
during the grower-finisher period. Therefore, the origin of M. hyopneumoniae infection in 
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grower-finisher herds was historically thought to occur via lateral transmission. However, 
a paradigm shift in the perception of M. hyopneumoniae infection and control was 
evidenced, as a new hypothesis of the epidemiology of the bacterium had been proposed 
(Pijoan, 2005). Considering three important epidemiological features of M. 
hyopneumoniae: 1) long shedding duration (Pieters et al., 2009); 2) slow transmission 
(Meyns et al., 2004), and 3) the positive association of M. hyopneumoniae pre-weaning 
prevalence with disease severity in finishing (Fano et al., 2007); the origin and severity of 
M. hyopneumoniae infection in grower-finisher herds has been suggested to be dependent 
upon sourcing sow herd(s) health status and stability. Such knowledge has shifted the 
industry’s focus to control M. hyopneumoniae infection at the sow herd level to influence 
disease outcome in downstream herds proactively. To further support such hypothesis, 
research aimed towards developing and applying molecular techniques to characterize M. 
hyopneumoniae is warranted. In doing so, insight of pathogen origin or inter-herd 
transmission may be gained, which can be utilized to optimize current strategies for 
disease prevention and control.      
1.3.3.4 Risk factors for infection 
During the lactation period, dam parity (Fano et al., 2006a; Sibila et al., 2007; 
Boonsoongnern et al., 2012), M. hyopneumoniae prevalence in farrowing dams (Pieters et 
al., 2014), lactation length (Pieters et al., 2014), cross-fostering (Nathues et al., 2013), 
and temperature at the farrowing stall-level (Nathues et al., 2013) are influential factors 
for piglet colonization. Mycoplasma hyopneumoniae prevalence is higher in pigs raised 
from gilts and young parity sows than those from intermediate and older parity sows 
(Fano et al., 2006a; Sibila et al., 2007b; Boonsoongnern et al., 2012), suggesting that gilts 
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and young parity sows can shed the pathogen more readily than other parities. Therefore, 
ensuring a negative infection status for gilts at first farrowing is considered paramount to 
reduce M. hyopneumoniae transmission to piglets (Pieters and Fano, 2016). Nevertheless, 
Calsamiglia and Pijoan (2000a) detected M. hyopneumoniae in the upper respiratory tract 
of intermediate to older parity sows (3rd to 7th parity). Other factors such as piglet gender 
and piglet birth weight were not associated with M. hyopneumoniae colonization at 
weaning (Nathues et al., 2013; Pieters et al., 2014).  
Differences in meteorological conditions may play a role in aerosol transmission 
of M. hyopneumoniae, as Dee et al. (2009) showed a strong association of PCR positive 
air samples with low sunlight levels and temperature. In contrast, other meteorological 
factors such as wind speed, relative humidity, and precipitation were not of significance 
for M. hyopneumoniae transmission. Conversely, Segalés et al. (2012) showed that a high 
precipitation rate and low temperature increased the probability of M. hyopneumoniae 
positive or seropositive pigs, respectively. It is important to note that meteorological 
conditions are often dependent upon topography and seasonality. There has been limited 
research assessing the role of topography on M. hyopneumoniae infection. Regarding 
seasonality, several studies have shown an increased probability for M. hyopneumoniae 
infections during the autumn and winter (Goodwin, 1985; Jorsal and Thomsen, 1998; 
Segalés et al., 2012).  
Introduction and transportation of replacement gilts remain important factors for 
swine pathogen entry into naïve herds. For genetic and production advancement, most 
commercial herds maintain a 40 to 60% replacement rate per year, requiring the 
introduction of gilts at various frequencies year-round (Patterson and Foxcroft, 2019). 
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Several biosecurity practices, including an isolation period and surveillance testing, are 
applied with varying accuracy to ensure the negative health status of replacement gilts 
(Neumann and Hall, 2019). Nevertheless, there is always a risk for either introducing a 
new pathogen into the herd or affecting herd stability.   
1.3.4 Diagnosis  
Mycoplasma hyopneumoniae diagnostic methods have been used to achieve many 
goals that focus on pathogen surveillance, monitoring, or obtaining a conclusive 
diagnosis. Although clinical signs and lung lesions may lead to a tentative diagnosis, 
diagnostic testing is critical for pathogen identification, confirmation, and management. 
Depending on the goal, the diagnostic outcome can be maximized through proper 
candidate, sample, and assay selection. 
1.3.4.1 Clinical diagnosis  
The first indication of disease attributed to M. hyopneumoniae is the observation 
of a chronic, non-productive cough. However, this clinical sign is not pathognomonic, as 
it can be caused by environmental factors and other infectious agents (Maes et al., 2018). 
The onset and severity of coughing can be inconsistent and differ based on infectious 
dose and strain (Vicca et al., 2003; Marois et al., 2010). Additionally, subclinical 
infection can occur, especially in recent and chronically infected pigs, thus posing 
challenges to recognize, let alone diagnose the disease. Given the poor diagnostic 
sensitivity and specificity attributed to clinical signs, laboratory testing is required for a 




1.3.4.2 Bacterial isolation  
Isolation of M. hyopneumoniae remains the gold-standard technique for 
confirming infection (Sibila et al., 2009), despite its low diagnostic sensitivity (2.6%; 
Friis, 1971). Due to the microorganism’s reliance on specific host nutrients for growth, 
isolation of M. hyopneumoniae is a fastidious process dependent on several factors, such 
as specialized medium, initial bacterial load, sample type, and presence of other bacteria 
(Kobisch and Friis, 1996; Friis, 1975). Nevertheless, there is interest to improve the 
isolation of M. hyopneumoniae for research purposes, establishment of antimicrobial 
susceptibility profiles, and improvement of vaccines. To increase the likelihood of 
bacterial isolation, a procedure to optimize donor selection, sample handling, and 
processing has been described (Anderson et al., 2016). Moreover, the use of 5% hyper-
immune anti-M. hyorhinis serum with 500 ug/ml cycloserine (Kobisch and Friis, 1996) 
and kanamycin in selective medium has been suggested to suppress M. hyorhinis growth 
(Cook et al., 2016), which is a frequent competitor during M. hyopneumoniae isolation.  
1.3.4.3 Detection of genetic material by PCR 
Although bacterial isolation is considered the gold standard for M. 
hyopneumoniae diagnostics, PCR assays are frequently employed for such purposes, as 
this method is extremely accurate and quick to perform. Several PCR assays have been 
developed for the detection of M. hyopneumoniae in antemortem and postmortem clinical 
samples (Calsamiglia et al., 1999; Dubosson et al., 2004; Strait et al., 2008). In the 1990s, 
conventional PCR methods were the first to be developed (Harasawa et al., 1991; 
Artiushin et al., 1993; Stemke et al., 1994; Mattson et al., 1995; Blanchard et al., 1996; 
Baumeister et al., 1998), followed by nested PCRs (Calsamiglia et al., 1999; Verdin et 
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al., 2000; Kurth et al., 2002), to improve assay sensitivity by amplifying a targeted region 
of the 16S rRNA gene with the two PCR reactions. Limitations with these PCR 
techniques include an increased likelihood for cross-contamination between samples 
during sample processing and amplification, along with a qualitative outcome. Over the 
years, species-specific real-time PCR assays (Dubosson et al., 2004; Strait et al., 2008) 
have been commonly utilized for M. hyopneumoniae detection instead of conventional 
methods. This shift has primarily occurred from diagnostic advancements and technology 
affordability, thus aiding the ability to obtain accurate results in real-time, while allowing 
for high and quick throughput with less laborious procedures. Moreover, real-time PCR 
techniques provide a semi- or quantitative value for the amount of genetic material 
detected, which can be used to understand the relative bacterial load in a sample. 
Real-time PCR assays are commonly employed for M. hyopneumoniae 
surveillance, monitoring, and diagnostic purposes. While PCR testing provides 
significant value towards guiding control and management methods, it is important to be 
mindful of possible pitfalls and variables that can influence assay outcome. Given that M. 
hyopneumoniae genetic material is detected, differentiation of live or dead bacteria is not 
feasible. Therefore, the interpretation of PCR results becomes most difficult after control 
or elimination strategies have been applied, as M. hyopneumoniae DNA has been 
detected post-antibiotic treatment (Painter et al., 2012), thus posing the question of 
present viable cells or uncleared genetic material from the respiratory tract. In addition, 
differences in M. hyopneumoniae PCR results have been described based on the material 
of the collection swab (Takeuti et al., 2017a), DNA extraction method (Vangroenweghe 
et al., 2015a), and sample type (Pieters et al., 2017; Sponheim et al., 2020).  
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Diagnostic sensitivity for M. hyopneumoniae detection by real-time PCR has been 
demonstrated to vary based on the type of sample collected and the infection phase. 
Using real-time PCR, M. hyopneumoniae DNA has been detected in various antemortem 
clinical samples, including nasal and laryngeal swabs, and tracheal secretions. Several 
studies have shown the collection of tracheal secretions via deep tracheal 
catheters/tracheo-bronchial swabs to have the highest diagnostic sensitivity for M. 
hyopneumoniae detection compared to laryngeal swabs (Sponheim et al., 2020) and nasal 
swabs (Kurth et al., 2002; Fablet et al., 2010; Vangroenweghe et al., 2015a) in both 
experimentally and naturally infected pigs. Additionally, Pieters et al., (2017) and Moiso 
et al. (2020) showed that laryngeal swabs were more sensitive than nasal swabs for M. 
hyopneumoniae detection under experimental and natural conditions, respectively. More 
recently, positive real-time PCR results have also been obtained from aggregated sample 
types, such as oral fluids (Pieters et al., 2017). Due to ease of collection and non-
invasiveness, the use of oral fluids for pathogen surveillance and monitoring has been of 
growing interest (Rotolo et al., 2016). However, very low sensitivity and inconsistent 
detection of M. hyopneumoniae have been described in oral fluids, especially during the 
early phase of infection (Pieters et al., 2017; Hernandez-Garcia et al., 2017; Sponheim et 
al., 2020). Mycoplasma hyopneumoniae has also been detected postmortem in bronchial 
swabs, lung tissue, and bronchoalveolar lavage fluid, of which bronchial swabs are the 
most sensitive (Kurth et al., 2002; Fablet et al., 2010; Pieters et al., 2017).   
1.3.4.4 Detection of antibodies  
A standard method to assess the serological response to M. hyopneumoniae is the 
Enzyme-Linked Immunosorbent Assay (ELISA). Enzyme-Linked Immunosorbent Assay 
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is frequently used for swine diagnostics because it is a rapid and inexpensive assay. 
Based on the context of use, ELISAs can provide insight towards determining the 
presence of maternally derived or acquired antibodies. Moreover, paired sera samples can 
be collected to evaluate infection or vaccine compliance. Several commercially available 
ELISAs have been developed for M. hyopneumoniae-specific IgG antibody detection, 
and vary based on assay type (i.e., indirect or blocking) and type of antigen used (i.e., 
whole cell or individual proteins; Pieters and Maes, 2019). In the United States, there are 
two commercially available ELISA assays, namely Idexx and Oxoid (i.e., Dako), referred 
to as indirect (I-ELISA) and blocking (B-ELISA) ELISAs, respectively, that are 
commonly used. Studies have indicated similar specificity for the two assays, whereas the 
B-ELISA is usually identified as numerically more sensitive than the I-ELISA (Ameri-
Mahabadi et al., 2005; Erlandson et al., 2005; Fano et al., 2012; Pieters et al., 2017). 
Therefore, B-ELISA is often used as a confirmatory test for I-ELISA when false-positive 
results are suspected. Sera samples have been primarily used to surveil for M. 
hyopneumoniae infection and/or establish immune status. Several studies have shown 
that seroconversion occurs four to six weeks post-inoculation and is a poor indicator for 
shedding (Pieters et al., 2009; Deegan et al., 2016; Roos et al., 2016; Pieters et al., 2017). 
It has been hypothesized that the delay in seroconversion may be due to a slower 
presentation of M. hyopneumoniae antigens to the host because this pathogen adheres to 
the ciliated respiratory epithelium and does not invade pulmonary tissue to the same 
extent as other pathogens (Sibila et al., 2009). Therefore, difficulties may arise for the 
assessment of early M. hyopneumoniae infections using ELISA. In addition, the accuracy 
of seroconversion assays can vary by vaccine product and dosage applied to hosts, cross-
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reactivity with antibodies to other bacteria (e.g., M. floccculare), and different test 
procedures (Sibilia et al., 2009; Ameri-Mahabadi et al., 2005). Moreover, there is an 
inability to differentiation seroconversion from vaccination or natural infection using 
ELISA. Due to these reasons, veterinarians are often challenged by the interpretation of 
serological results and making inferences without vaccine history and additional 
diagnostics.  
1.3.4.5 Antigenic assays 
An immunohistochemistry (IHC) assay was developed to detect M. 
hyopneumoniae antigen in tissues (Amanfu et al., 1984). Despite the ability to correlate 
antigen presence with microscopic lesions, there are several drawbacks to this assay. 
Lung tissue is required to conduct the IHC assay, however, the opportunity to collect 
postmortem samples is not always an option, especially when multiple animals are 
recommended for a conclusive diagnosis. Moreover, a small amount of tissue is 
evaluated, increasing the likelihood of obtaining a false negative result. Furthermore, a 
highly specific monoclonal antibody is necessary to decrease the occurrence of false 
positives.  
1.3.5 Molecular epidemiology  
1.3.5.1 Genomic diversity  
The M. hyopneumoniae genome has been fully sequenced for six strains and has 
been described to be composed of 892,758-964,503 base pairs and contain a low G + C 
content of 28.4-28.6% (Minion et al., 2004; Vasconcelos et al., 2005; Liu et al., 2011; 
Siqueira et al., 2013; Han et al., 2017). Also, 679-695 predicted protein-coding sequences 
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have been described, in which 44-62%, 14-38%, and 18-23% encode for functional, 
conserved, or unique hypothetical proteins, respectively (Minion et al., 2004; 
Vasconcelos et al., 2005; Siqueira et al., 2013). Like other Mycoplasmas, M. 
hyopneumoniae can modify gene and antigenic expression, primarily during DNA 
replication (Minion et al., 2004). Within many lipoprotein and adhesion encoding genes, 
repetitive tandem regions of DNA, known as Variable Number Tandem Repeats 
(VNTRs), are present and undergo phase variation, recombination, and slipped strand 
mispairing during replication. Thus, resulting in adherence and antigenic variation from 
modifications in cell surface structure (Razin et al., 1998; Rosengarten et al., 2000; 
Minion et al., 2000; de Castro et al., 2006). Differences in VNTR length of several 
adhesins and chromosomal restriction patterns have been described across M. 
hyopneumoniae strains and isolates using whole genome or individual gene sequencing 
(Hsu et al., 1998; Vasconcelos et al., 2005; Garza-Moreno et al., 2019), field inversion 
gel electrophoresis (Frey et al., 1992), and random amplified polymorphism DNA 
analysis (Artiushin et al., 1996).  
Using various molecular techniques, M. hyopneumoniae genomic diversity has 
been summarized across different geographic and population levels (Betlach et al., 2019). 
From a geographical standpoint, increased genomic heterogeneity has been demonstrated 
across M. hyopneumoniae isolates and strains originating from diverse regions (i.e., 
different countries) compared to those originating from a more localized region (Frey et 
al., 1992; Dos Santos et al., 2015). Several M. hyopneumoniae VNTR types have been 
identified within a country and individual state, suggesting considerable variability of 
VNTR types in swine populations (Vranckx et al., 2011; Dos Santos et al., 2015; Takeuti 
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et al., 2017b). Among all types detected in different countries (i.e., United States, 
Mexico, Brazil, and Spain), a common M. hyopneumoniae VNTR type has not been 
detected (Dos Santos et al., 2015). In swine-dense geographical areas, multiple M. 
hyopneumoniae VNTR types have been identified in endemically infected herds and even 
in individual pigs (Vranckx et al., 2011; Nathues et al., 2011; Michiels et al., 2017; Tonni 
et al., 2021). Great homogeneity and/or identical M. hyopneumoniae VNTR types in 
herds that are in close geographical proximity, or herds that belong to the same 
production flow, has also been shown (Mayor et al., 2007; Charlebois et al., 2014; 
Pantoja et al., 2016; Takeuti et al., 2017b; Rebaque et al., 2018). In all cases, one distinct 
M. hyopneumoniae VNTR type along with multiple clonal types (i.e., similar VNTR 
types) have been described. It could be hypothesized that the degree of M. 
hyopneumoniae genetic variability among herds might be influenced by herd 
management. However, potential drivers and mechanisms of genetic heterogeneity have 
been poorly explored and defined. 
1.3.5.2 Molecular characterization techniques  
Several techniques have been standardized to molecularly characterize M. 
hyopneumoniae using nucleic acid amplification, including Amplified Fragment Length 
Polymorphism (AFLP; Kokotovic et al., 1999; Stakenborg et al., 2006), Restriction 
Amplified Polymorphic DNA analysis (RAPD; Artiushin and Minion, 1996; Vicca et al., 
2003), Pulse-Field Gel Electrophoresis (PFGE; Stakenborg et al., 2006), Random 
Fragment Length Polymorphism (RFLP; Stakenborg et al., 2006), and DNA Microarrays 
(Madsen et al., 2007). However, variations in reproducibility, feasibility, and 
discriminatory power exist among these molecular techniques (Stakenborg et al., 2006; 
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Sibila et al., 2009). To provide further discrimination, Multiple-Locus Sequence Typing 
(MLST; Mayor et al., 2008), MLVA (Vranckx et al., 2011; Nathues et al., 2011; Dos 
Santos et al., 2015; Tamiozzo et al., 2015), complete or partial gene sequencing (Tsungda 
and Minion, 1998; Mayor et al., 2007; Garza-Moreno et al., 2019), and whole genome 
sequencing (Minion et al., 2004; Vasconcelos et al., 2005; Liu et al., 2011; Siqueira et al., 
2013; Han et al., 2017) have been recently employed. While each molecular method has 
its strengths and disadvantages, it is important to consider the question at hand, resources 
available, and capabilities that each method can provide before utilizing such techniques.  
Thus far, molecular characterization techniques for M. hyopneumoniae have been 
commonly employed in research settings. However, the application of M. hyopneumoniae 
characterization in field investigations has increased in the United States to provide 
veterinarians additional insight into the transmission and control of this microorganism. 
Although whole genome sequencing has been proposed as a highly descriptive and 
thorough method, the routine application of this technique for disease investigations may 
pose difficulties based on its current practicality, feasibility, and long turn-around time, 
as it applies to disease investigations. Moreover, pathogen isolates are commonly used 
for whole genome sequencing to achieve a high sequence coverage by limiting the 
presence of host DNA contamination that exists in clinical samples. However, one 
bottleneck for the whole genome sequencing of M. hyopneumoniae is the poor feasibility 
to obtain isolates. Therefore, the utilization of typing methods (i.e., MLVA) and complete 
or partial-gene sequencing for M. hyopneumoniae characterization have increased in 
veterinary diagnostic laboratories, as the control and elimination of this microorganism is 
widely attempted worldwide (Maes et al., 2018).  
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1.3.5.3  Typing methods 
The most employed genomic typing methods for M. hyopneumoniae are MLST 
and MLVA. The MLST assay has been utilized for many bacterial species and was 
standardized for the molecular characterization of M. hyopneumoniae by Mayor et al. 
(2008). Several loci have been targeted, including putative and house-keeping genes (i.e., 
efp, metG, pgiB, recA, adk, rpoB, tpiA, gyrB, and gmk). As identified in Mycoplasma 
spp., house-keeping genes have been described to be highly conserved, resulting in 
limited variation among strains (Dumke et al., 2003). The MLVA assay is a typing 
method that identifies the number of VNTRs within surface proteins and has been 
employed for the molecular characterization of M. hyopneumoniae in Spain, Argentina, 
Belgium, United States, Mexico, and Brazil (de Castro et al., 2006; Vranckx et al., 2011; 
Dos Santos et al., 2015; Tamiozzo et al., 2015; Takeuti et al., 2017b; Michiels et al., 
2017). Several techniques have described the M. hyopneumoniae variability using 
different loci numbers (e.g., 2 or 4) and types (i.e., P97, P146, H1, H4, H5). The targeted 
loci have been selected for their presumed bacterial adherent capability to the ciliated 
epithelium, presence of repetitive, tandem repeats, or a high degree of variability 
(Vranckx et al., 2011; Dos Santos et al., 2015; Tamiozzo et al., 2015; Rebaque et al., 
2018).  Currently, MLVA assay is commonly performed and has been implemented for 
epidemiological investigations due to its high discriminatory power, reproducibility, and 
use of clinical samples (Vranckx et al., 2011; Dos Santos et al., 2015). Despite this, 
discrepancies regarding the genomic characterization of M. hyopneumoniae and 
interpretation currently exist. Like other typing methods, MLVA evaluates few and 
29 
 
specific genomic areas. Therefore, other areas within the genome that may contribute to 
variability may be unrepresented.  
1.3.5.4 Sequencing methods 
Genomic sequencing methods have been developed to evaluate the entire genome 
or individual genes of M. hyopneumoniae. To further explore how the genomic structure 
of M. hyopneumoniae can influence pathogenesis and host-pathogen interaction, whole- 
genome sequencing has been attempted (Minion et al., 2004; Vasconcelos et al., 2005; 
Liu et al., 2011; Siqueira et al., 2013; Han et al., 2017). While this molecular technique 
offers descriptive and thorough information, the feasibility to routinely perform whole- 
genome sequencing may be limited due to cost, the difficulty of interpretation, 
computational requirements, and the need for sophisticated equipment. Therefore, 
complete or partial sequencing of individual M. hyopneumoniae genes has been 
attempted (Mayor et al., 2007; Felde et al., 2018). Due to the paralogous nature of P146 
with P97, and the presence of distinct motifs and consensus regions (i.e., PQ, S, PS for 
locus P146), partial sequencing of the encoded gene mhp 684 (3954 bp) has been 
previously described (Mayor et al., 2007; Bogema et al., 2012). Throughout the 
employment of sequencing methods, the number of VNTRs has also been evaluated for 
M. hyopneumoniae (Felde et al., 2018; Garza-Moreno et al., 2019). However, as with 
MLVA, there is limited knowledge on the interpretation of sequencing methods and the 
insight gained from the comparison of molecular assays that evaluate nucleotide 




1.3.5.5 Field application 
Utilization of molecular techniques can aid in the characterization and genetic 
comparison of M. hyopneumoniae variants. In doing so, insight related to pathogen 
origin, transmission, and potential evolution can be gained. Nevertheless, molecular 
characterization techniques have not been commonly used in the field. One of the reasons 
is because genomic classification criteria for M. hyopneumoniae have not been 
established due to the limited comparison of currently available molecular techniques. 
Another reason is the poor understanding of the biological importance of genetic 
variability in M. hyopneumoniae. An improved understanding of the M. hyopneumoniae 
diversity via the comparison of commonly used molecular characterization techniques is 
warranted to aid in epidemiological investigations and pathogen tracing. 
1.3.6  Surveillance 
Surveillance is often defined as the ‘ongoing and systematic collection, analysis, 
and interpretation of health data aimed at early detection of a specific disease or agent in 
a population, or identifying an elevated risk of acquiring an infectious disease to 
maximize prevention and control’ (Thurmond, 2003). The design of surveillance 
strategies is a function of temporality and its ability to accurately identify the presence of 
an infectious agent in a population at any given time. Surveillance strategies should 
maximize the probability of true early detection while minimizing the probability of 
false-positive detection (Thurmond, 2003). Attributes that define a surveillance strategy 
include accuracy, precision, rapidity, efficiency, and value. Given their perceived risk for 
disease introduction to breeding herds, replacement gilts are routinely surveilled for 
significant pathogens, including M. hyopneumoniae (Neumann and Hall, 2019). 
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Historically, the design of surveillance strategies in replacement gilt populations has been 
based on the assumption of perfect accuracy (Cannon and Roe, 1982) and the capability 
for multi-pathogen testing. Nevertheless, the question for potential false diagnostic 
assurance arises from the poor diagnostic sensitivity described for M. hyopneumoniae, 
given certain sample types and timing (Pieters et al., 2017; Sponheim et al., 2020). 
Therefore, the ability to detect a recent M. hyopneumoniae infection using currently 
available sample types warrants further investigation to improve strategies to aid in 
disease prevention and control. Also, surveillance strategies were designed based on the 
fact that more recent sample techniques and diagnostic tools were not available or had not 
been researched. With the more recent development of alternative clinical samples and 
diagnostic tests, there is a need to re-evaluate current surveillance strategies 
1.3.7 Control and elimination 
1.3.7.1 Classification of herd health status 
Initiation of a disease control plan centers around the assessment of the herd 
health status. Assessment of herd health status involves a comprehensive analysis of 
clinical and diagnostic data for both the recipient sow herds and incoming gilt 
populations, which can be utilized to best guide control strategies for the herd of interest. 
A classification of M. hyopneumoniae health status has been initially proposed by Garza-
Moreno et al. (2018) and later by the American Association of Swine Veterinarians 
(AASV, 2019), which groups recipient sow herds and/or incoming replacement gilt 
populations into different categories based on the presence of clinical signs and lung 




1.3.7.2 Management methods  
Optimization of management practices and housing conditions to either lessen the 
spread of M. hyopneumoniae or reduce disease severity should be initially accomplished 
to control disease. Management of pigs using all-in, all-out production has been shown to 
control M. hyopneumoniae by allowing for breaks in pathogen transmission between 
populations of differing ages and health dynamics, tailored environmental conditions, and 
facility disinfection (Clark et al., 1991). Early weaning and parity segregation have also 
been employed to reduce pathogen transmission from dams to offspring (Alexander et al., 
1980; Dee, 1994). However, the routine implementation of early weaning and parity 
segregation is not always feasible and can pose challenges with production. Reduction of 
herd size and animal stocking density and improvement of biosecurity measures can also 
be implemented to reduce the spread of M. hyopneumoniae within or between pig cohorts 
(Maes et al., 2008).  
1.3.7.3 Gilt acclimation  
Continued pathogen transmission and herd instability may exist in infected 
populations that receive naïve replacement gilts. In the swine industry, this challenge has 
become a norm due to economic, production, and health factors associated with 
purchasing high health replacement gilts (Pieters and Fano, 2016). Several strategies, 
including vaccination, gilt flow management, and controlled exposure, have been 
practiced to acclimate gilts to pathogens that are endemically present in the recipient 
herd, with the purpose of ensuring immunity and decreasing pathogen circulation (Fano 
and Payne, 2015; Garza-Moreno et al., 2018). Vaccination is the most common 
acclimatization method, and works by inducing immunity against M. hyopneumoniae 
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before entry into sow herds. However, this intervention’s inherent limitations, such as 
incomplete protection from infection, has driven the utilization of other acclimation 
options. Since M. hyopneumoniae infection is usually maintained in herds, clinically 
affected older gilts and sows have been used as “seeders” to amplify and shed the 
bacterium to younger gilts. Nevertheless, the nature of the pathogen is the limiting factor 
for this type of exposure. Roos et al. (2016) proposed that a 1:1 ratio of seeder to 
susceptible gilts is necessary to ensure that all gilts have been exposed to the pathogen in 
a relatively short period of time (4 weeks). In the field, this method is not feasible and/or 
practical due to limited space and facility requirements and the large number of infected 
non-select or culled animals that would be  to act as seeders. For the reason described 
above, controlled exposure of susceptible gilts to a herd-specific M. hyopneumoniae lung 
homogenate has been proposed and applied in the field (Robbins et al., 2016; Figueras et 
al., 2020).  The control exposure strategy has also been utilized in M. hyopneumoniae 
elimination efforts to establish a homogeneous health status at the start of the closure 
(i.e., Day 0; Holst et al., 2015; Yeske et al., 2020).  
1.3.7.4 Vaccines 
Commercial vaccines, consisting of inactivated and adjuvanted whole-cell 
preparations, are commonly utilized to control M. hyopneumoniae infection. Studies have 
shown beneficial vaccination effects, including the reduction of M. hyopneumoniae 
bacterial load, improvement in growth performance, and decrease in disease severity 
(Maes et al.,1998; Maes et al., 1999; Fano et al., 2006b; Meyns et al., 2006; Sibila et al., 
2007a; Vranckx et al., 2012a). Despite their wide use, partial protection against M. 
hyopneumoniae infection is induced (Meyns et al., 2006; Pieters et al., 2010; Villarreal et 
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al., 2011b). While the mechanisms for protection are not yet fully understood, the 
induction of localized mucosal antibodies and cell-mediated immunity has been 
suggested to play an important role in protection (Maes et al., 2020a). Different 
vaccination strategies have been adopted to optimize disease control, depending on the 
production stage, management practices, and herd infection dynamics. In the field, M. 
hyopneumoniae bacterins are often administered to weaned piglets since colonization has 
been shown to occur from the first weeks of life (reviewed by Haesebrouck et al., 2004; 
Sibila et al., 2007b) and to provide ample time for development of an immune response 
prior to disease presentation. Moreover, incoming replacement gilts are often vaccinated 
for acclimation purposes (Garza-Moreno et al., 2018).  
Vaccine efficacy has been shown to vary based on vaccination timing and the 
number of doses and is improved when multiple doses are administered (Baccaro et al., 
2006; Sibila et al., 2007a, Arsenakis et al., 2017; Garza-Moreno et al., 2019). However, 
the indirect effect of vaccination on reducing infection pressure in a population remains 
poorly understood. Several studies described a numerical reduction in M. hyopneumoniae 
transmission when one or two vaccine doses were administered to either infected or 
susceptible pigs (Meyns et al., 2006; Pieters et al., 2010; Villarreal et al., 2011). 
Nevertheless, the combined effect of multiple vaccinations in both populations, infected 
and susceptible gilts, on M. hyopneumoniae transmission remains unclear. Given that 
susceptible subpopulations are often present in an infected herd, additional research to 




Antibiotics are considered paramount for the control of M. hyopneumoniae 
infection. Antibiotics effective against M. hyopneumoniae include tetracyclines, 15-and 
16-membered lactone ring macrolides, fluoroquinolones, lincosamides, florfenicol, and 
aminoglycosides (Gautier-Bouchardon, 2019). Mycoplasma hyopneumoniae is 
intrinsically resistant to antibiotics that target cell wall synthesis (e.g., ꞵ-lactams), as well 
as to 14-membered lactone ring macrolides. Studies have shown antibiotics to reduce the 
bacterial load and to mitigate M. hyopneumoniae-associated disease (Del Pozo Sacristan, 
2014; Maes et al., 2017). In addition, antibiotics are commonly employed in M. 
hyopneumoniae elimination strategies (Holst et al., 2015). Despite their known 
antibacterial effects, there has been no information suggesting that antibiotics alter the 
transmissibility of M. hyopneumoniae. Knowledge on the effect of antibiotics on 
transmission would guide the time at which antibiotic treatment is applied to lessen 
pathogen spread, especially for outbreak scenarios. Post-treatment, the persistence of M. 
hyopneumoniae infection has been suspected due to the detection of genetic material by 
real-time PCR in clinical samples collected from treated pigs (Thacker et al., 2006; Le 
Carrou et al., 2006; Painter et al., 2012), or the lingering of clinical signs. Acquired 
antibiotic resistance has been described for M. hyopneumoniae (Maes et al., 2020b), but it 
has been evaluated to a limited extent due to bacterial isolation challenges. Therefore, the 
infectious potential of the bacterium post-antibiotic treatment has not been investigated 
in-vivo.  
1.3.7.6 Elimination strategies 
Overall, the foundation of a successful elimination program is built mainly upon 
the ability to prevent pathogen transmission, reduce infection prevalence, and later 
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confirm freedom of disease. While this concept can pertain to almost any pathogen, 
elimination protocols are often tailored towards a specific infectious agent. For M. 
hyopneumoniae, four elimination strategies, namely 1) depopulation and repopulation; 2) 
partial depopulation (Swiss Method); 3) Herd closure and medication; 4) Whole herd 
medication, have been mostly employed (Holst et al., 2015). The process for strategy 
selection is often dependent upon several factors, including but not limited to herd 
structure, the ability for continued production, feasibility, available resources, and the 
likelihood of success.  
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Table 1.1 Classification and clinical-pathological presentation of common swine Mycoplasmas 








M. hyopneumoniae Hominis; Neurolyticum Pathogenic Pneumonia Goodwin et al., 1965;  
Maré and Switzer, 
1965 
 








Friis, 1975; Friis and 
Feenstra, 1994; 
Roberts et al., 1963; 
Morita et al., 1998; 
Lin et al., 2006; 
Pereira et al., 2017; 
Luehrs et al., 2017;  
Resende et al., 2019 
M. hyosynoviae Hominis; Hominis Opportunistic Arthritis Ross and Duncan, 
1970; Hagedorn-
Olson et al., 1999a 
 
M. suis  
(formerly known as 
Eperythrozoon suis) 
 
Haemominutum Pathogenic Anemia Splitter, 1950 
 
M. flocculare Hominis; Neurolyticum Commensal  Meyling and Friis, 
1972 
 




Figure 1.1 Timeline of infection dynamics and detection of Mycoplasma hyopneumoniae 
under experimental conditions 
Gray shading represents the likelihood of genetic material or antibody detection for M. hyopneumoniae, 
with darkest gray shade having the highest likelihood. Onset and duration of gray shading is proposed 







Chapter 2: Natural transmission of Mycoplasma hyopneumoniae in a 
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Betlach, A.M., Valeris-Chacin, R., Singer, R.S., Allerson, M., Pieters, M. 2020. Natural 
transmission and detection of Mycoplasma hyopneumoniae in a naïve gilt population. 








Mycoplasma hyopneumoniae (M. hyopneumoniae) continues to be a prevalent and 
economically important swine respiratory pathogen. For M. hyopneumoniae surveillance, 
blood samples and/or oral fluids are commonly collected from incoming replacement 
gilts prior to entering sow herds. However, limitations to this approach exist, particularly 
due to low sensitivity during acute stages of natural infection, leading to diagnostic 
uncertainty. Therefore, the objective of this study was to evaluate the natural transmission 
and detection of M. hyopneumoniae based on the introduction of one infected gilt to a 
naïve population. Twenty-nine naïve gilts were housed with one M. hyopneumoniae 
naturally exposed gilt for 8 weeks. Deep tracheal catheters, laryngeal swabs, and blood 
samples were individually collected from each gilt at 0, 1, 2, 4, 6, and 8 weeks post-
contact (wpc), along with one pen-based oral fluid sample. Blood samples were assayed 
by ELISA, while all other samples were tested by real-time PCR. The transmission rate 
of M. hyopneumoniae (ꞵ) was estimated using a Bayesian mixed-effects generalized 
linear model. At 8 wpc, 27% (8/29) of the naïve gilts had become infected (ꞵ=0.73 new 
infected gilts/gilt-week). Seroconversion was detected in 3% of contact gilts at 8 wpc. 
Oral fluids were negative for M. hyopneumoniae at all samplings. In this study, the 
natural transmission of M. hyopneumoniae was slow and detection varied based on 
sample type and timing. Thus, M. hyopneumoniae surveillance protocols should include 
lower respiratory tract samples that are tested by real-time PCR to avoid the introduction 






Mycoplasma hyopneumoniae (M. hyopneumoniae) is a host-specific bacterium 
that causes enzootic pneumonia in swine (Maré and Switzer, 1965; Goodwin et al., 
1965). Signs suggestive of M. hyopneumoniae infection consist of dry cough, labored 
breathing, and reduced growth rate. Mycoplasma hyopneumoniae is mainly transmitted 
through direct contact between infected and susceptible pigs (Pieters and Maes et al., 
2019).   
Replacement gilt introduction is practiced in the swine industry for genetic 
advancement, maintenance of parity distribution, and productivity of sow herds 
(Patterson and Foxcroft, 2019).  Nevertheless, replacement gilts are perceived as a risk 
for pathogen entry due to their frequent introduction year-round. Biosecurity practices, 
including varying isolation periods (1-6 weeks), and/or vaccination, and routine 
surveillance testing prior to sow herd entry are implemented to minimize pathogen 
introduction and to assure gilt health status (Neumann and Hall, 2019). The most 
common surveillance protocol entails testing 30 individual gilt blood samples by ELISA, 
assuming perfect accuracy (Cannon and Roe, 1982), along with PCR testing of aggregate 
samples (e.g. oral fluids; Rotolo et al., 2017). Blood samples and oral fluids are the most 
utilized sample types due to ease of collection and ability for multi-pathogen testing. 
However, the ability to detect multiple pathogens in one sample can vary significantly 
given differences in the pathogenesis, diagnosis, and epidemiology between pathogens.  
The detection of M. hyopneumoniae or its antibodies in oral fluids or serum, 
respectively, is challenging in the acute stages of infection (Pieters et al., 2017) due to 
poor diagnostic sensitivity and delayed seroconversion, thus leading to false diagnostic 
42 
 
assurance. Gilts are often vaccinated against M. hyopneumoniae prior to entering the sow 
herd, which could further complicate the interpretation of serological results. Moreover, 
under experimental conditions, the spread of M. hyopneumoniae in a population has been 
described to be slow, ranging from 0.56-1.16 new infections per infected pig in a 6-week 
period (Meyns et al., 2004, Villarreal et al., 2011). Nevertheless, M. hyopneumoniae 
transmission and detection may vary in naturally infected pigs. Therefore, the objective 
of this study was to evaluate the natural transmission and detection of M. hyopneumoniae 
based on the introduction of one infected gilt to a naïve population.  
2.3 Materials and methods 
2.3.1 Animals and housing 
Thirty-two 7-week old gilts were obtained from a M. hyopneumoniae and Porcine 
Reproductive and Respiratory Syndrome Virus negative source and were housed at a 
filtered biosafety level-2 experimental isolation unit. A history of more than five years of 
negativity to M. hyopneumoniae infection, absence of clinical signs, and supportive 
diagnostic records were used to verify health status. Mycoplasma hyopneumoniae naive 
status was confirmed in all gilts via the absence of antibodies and lack of detection of M. 
hyopneumoniae using deep tracheal catheters tested by real-time PCR. The study was 
conducted according to project-specific protocols, which were approved by the Swine 
Services Unlimited Inc. ethical review board, based on institutional animal care and use 





3.3.2 Study design  
A graphical representation of the study design is provided in Figure 2.1. Briefly, 
gilts were transported to the isolation unit at two different time points for the different 
study phases, namely 1) Development of natural seeder and 2) Natural transmission. 
Upon arrival, gilts were randomly selected and ear-tagged. For the first study phase, two 
gilts were experimentally inoculated with M. hyopneumoniae and housed with one 
contact gilt until natural infection in the contact gilt (natural seeder) occurred. For the 
second study phase, the natural seeder was relocated to a clean, experimental room, 
where it was housed with 29 contact naïve gilts for eight weeks. As a result, the initial M. 
hyopneumoniae prevalence was 3%. To assess transmission and detection, blood, 
laryngeal swabs, and deep tracheal catheters were individually collected from each gilt at 
0, 1, 2, 4, 6, and 8 weeks post-contact (wpc), along with the collection of one pen-based 
oral fluid sample. Gilts were sampled at these specific time points to mimic various 
isolation lengths that are implemented in the field. At the end of the study, gilts were 
humanely euthanized using electrocution and bronchial swabs and lung tissue samples 
were collected, along with the evaluation of lung lesions.   
2.3.2.1 Development of natural seeder 
Two gilts were experimentally inoculated with 15 mL of lung homogenate 
containing 1x105 CCU/mL of a moderately virulent M. hyopneumoniae strain (232; 
Minion et al., 2004) via intra-tracheal (Gomes Neto et al., 2014). The experimentally 
infected gilts were confirmed M. hyopneumoniae positive by real-time PCR in laryngeal 
swabs and deep tracheal catheters at 7 days post-inoculation (dpi) and were comingled in 
the same pen (1.02 m2/gilt) with a contact naïve gilt to induce the development of a 
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natural seeder. Laryngeal swabs and deep tracheal catheters were collected from the 
contact gilt every 3 to 6 days to monitor for infection. Once the contact gilt was 
confirmed M. hyopneumoniae positive in both sample types, the gilt was considered a 
natural seeder, assigned a new ear tag and was relocated to a different room for the 
second study phase. The experimentally infected gilts were euthanized at this time point. 
2.3.2.2 Natural transmission  
At day 0, the natural seeder was commingled with 29 contact gilts in a separate 
experimental room. Gilts were housed in single pen (1.45 m2/gilt) throughout the duration 
of the study. At 0, 1, 2, 4, 6, and 8 wpc, blood, laryngeal swabs and deep tracheal 
catheters were collected from each individual gilt, along with one oral fluid sample at the 
pen level. Investigators were masked to gilt identification to avoid sampling bias. At each 
sampling event, samples were collected in a routine fashion in this order: laryngeal swab, 
deep tracheal catheter and blood. The sampling equipment was disinfected between 
individual gilts to avoid cross-contamination. In addition, individual coughs were 
recorded daily for 30 min at the same time of the day. All gilts were humanely euthanized 
at 8 wpc, followed by collection of bronchial swabs and lung tissue samples, and 
evaluation of lung lesions.  
2.3.3  Sample collection and processing 
Laryngeal swabs were collected from each gilt as previously described by Pieters 
et al. (2017), using sterile collection swabs (BBLTM CultureSwabTM, Sparks, MD, USA), 
mouth speculum, and using a hemostat to lengthen the swab reach as gilts aged 
(Sponheim et al., 2020). Deep tracheal catheters were collected by intra-tracheally 
45 
 
introducing a sterile, red rubber catheter (Covidien, Mansfield, MA, USA) into the mouth 
of each gilt, as described by Fablet et al. (2010). After collection, the tip of each catheter 
was inserted into a sterile 5mL tube containing 500ul of phosphate-buffered saline and 
later vortexed to obtain tracheal secretions. Oral fluid samples were collected as 
previously described by Prickett and Zimmerman (2010). Briefly, a 60.9 cm long cotton 
rope was hung in the center of the pen and suspended at pig shoulder height. Oral fluids 
were manually extracted and transferred to sterile tubes. Bronchial swabs were collected 
from each gilt after euthanasia as described by Pieters et al. (2009). Laryngeal and 
bronchial swabs, deep tracheal catheters, and oral fluids were stored at -20oC until 
processing, and were individually processed for DNA extraction using MagMAXTM-96 
Viral RNA isolation kit and MagMAXTM Express-96 Magnetic Particle Processor (Life 
Technologies, Grand Island, NY, USA). The extracted genetic material was tested for M. 
hyopneumoniae using species-specific real-time PCR with VetMAXTM qPCR Master Mix 
and VetMAXTM M. hyopneumoniae Reagents kit (Life Technologies, Grand Island, NY, 
USA), following manufacturers protocol. Samples were considered positive with a <40 
Ct value.  
Blood samples were submitted to the University of Minnesota, Veterinary 
Diagnostic Laboratory (UMN-VDL) for the detection of M. hyopneumoniae antibodies 
using an indirect ELISA test (Idexx Laboratories, Westbrook, ME, USA). Samples were 
considered positive with a ≥ 0.4 S/P ratio.  
Gross lung lesions were scored on a scale from 0 to 100% depending on lesion 
severity and anatomical lobe (Pointon et al., 1999). Lung tissue samples were collected in 
the transitional area when lesions were evident or in a consistent area if lesions were 
46 
 
absent. Tissue samples were fixed in 10% buffered formalin and evaluated for 
histopathology at the UMN-VDL. Microscopic lung lesions were assessed and scored on 
a scale from 0 to 4 as previously described (Thacker et al., 1999).  
2.3.4 Diagnostic criterion  
Gilts were determined to be infected with M. hyopneumoniae based on a parallel 
interpretation of diagnostic results at the individual level, thus if either of the real-time 
PCR results were positive, the corresponding gilt was considered infected.  
2.3.5  Data analysis  
Antemortem samples were compared by evaluating the time-to-detection for M. 
hyopneumoniae based on a Cox Proportional Hazard Regression model, while 
incorporating shared frailty for gilt. The proportional hazards assumption was assessed 
using cox.zph function from the package survival (Therneau, 2015) in R Studio® version 
3.6.1 (R Core Team, 2019, Vienna, Austria). A p-value <0.05 was used to determine 
statistical significance. Mycoplasma hyopneumoniae transmission parameters were 
evaluated using a susceptible-infectious (SI) model. Equal susceptibility was assumed, 
and M. hyopneumoniae positive gilts remained infectious for the duration of the study 
with a lack of recovery. The transmission rate (ꞵ) per week was estimated during the 8-
week period of the study (t=8) using a Bayesian mixed-effects generalized linear model 
with family binomial, complementary log-log link function and a log I/N (ratio of 
infected(I)/total population(N)) as offset, while incorporating gilt as random intercept. 
The model was conducted using Stata 16 (StataCorp, Release 16, 2019, College Station, 
TX, USA). The probability that a susceptible gilt became infected was 1-e-ꞵΔtI/N (Velthuis 
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et al., 2003). The transmission rates from previous M. hyopneumoniae transmission 
studies (Meyns et al., 2004; Villarreal et al., 2011; Roos et al., 2016) were used to build a 
prior distribution. As a result, a normal prior for the log transmission rate with a mean 
and variance of -0.12 and 1.59, respectively, was employed. Four Markov chain Monte 
Carlo chains were run with 100,000 iterations each after a burn-in of 5,000 iterations. The 
adjusted reproductive ratio (Rn) was estimated by multiplying ꞵ by the duration of 
infection. Since M. hyopneumoniae can shed for up to 214 days (Pieters et al., 2009), the 
duration of infection was equivalent to the length of study.  
2.4  Results 
2.4.1  Development of natural seeder  
At 7 dpi,  both experimentally inoculated gilts were M. hyopneumoniae positive 
by real-time PCR (Ct values 20.19 and 25.06). At 23 dpc, M. hyopneumoniae was 
detected by real-time PCR in both the deep tracheal catheter and laryngeal swab (Ct 
values 35.7 and 36.2, respectively) in the contact gilt, thus confirming the development of 
a natural seeder.  
2.4.2 Natural transmission 
2.4.2.1 Ante-mortem detection of M. hyopneumoniae, seroconversion, and clinical signs 
Detection of M. hyopneumoniae by real-time PCR in all sample types and 
serological detection of antibodies in the natural seeder and contact naïve gilts is shown 
in Table 2.1. Throughout the natural transmission phase (0-8 wpc), M. hyopneumoniae 
was consistently detected by real-time PCR in deep tracheal catheters collected from the 
natural seeder, resulting in 100% sensitivity. Detection of M. hyopneumoniae by real-
time PCR in laryngeal swabs showed 83.3% sensitivity, as one false negative result was 
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obtained at 4 wpc. The natural seeder was seropositive for M. hyopneumoniae at 6 and 8 
wpc, resulting in 33.3% sensitivity in blood samples by ELISA.  
At 0 wpc, all contact gilts (n=29) were confirmed M. hyopneumoniae negative in deep 
tracheal catheters and laryngeal swabs. Contact gilts remained negative to M. 
hyopneumoniae detection by real-time PCR until 4 wpc. At 6 wpc, 3.4% (1/29) of contact 
gilts tested positive for M. hyopneumoniae in laryngeal swabs and deep tracheal 
catheters. At 8 wpc, M. hyopneumoniae was detected in 3.4% (1/29) and 17.2% (5/29) of 
contact gilts in laryngeal swabs and deep tracheal catheters, respectively, and 3.4% (1/29) 
of contact gilts were seropositive.  
When analyzing with the Cox Proportional Hazard Regression model, the hazard 
of detection of secondary M. hyopneumoniae infections in deep tracheal catheters by real-
time PCR was 12.67 times the hazard of detection of secondary M. hyopneumoniae 
infections in blood samples by ELISA (95% CI: 1.3, 123.3; p=0.02). The hazard ratio of 
M. hyopneumoniae detection by real-time PCR in deep tracheal catheters compared to 
laryngeal swabs was 6.96  (95% CI: 0.79, 61.3; p=0.08). Moreover, the hazard ratio of 
detection of secondary M. hyopneumoniae infections in laryngeal swabs when using real-
time PCR was 1.82 times the hazard of detection of secondary M. hyopneumoniae 
infections in blood samples when using ELISA (95% CI: 0.10, 31.9; p=0.68). 
Assumption of hazard proportionality was met, suggesting that the hazard ratio of M. 
hyopneumoniae detection, given any of the two evaluated sample types, was constant 
over time. The overall effect of sample type on time-to-detection of M. hyopneumoniae 
did not reach statistical significance (p=0.06). All oral fluids were M. hyopneumoniae 
negative by real-time PCR throughout the study. Coughing was observed in the natural 
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seeder and in one M. hyopneumoniae infected contact gilt at 3.3 wpc and 7.5 wpc, 
respectively. Coughing gilts were also M. hyopneumoniae positive by real-time PCR 
prior to the onset of coughing. 
2.4.2.2 Postmortem detection of M. hyopneumoniae and lung lesion scores 
At necropsy (8wpc), M hyopneumoniae was detected by real-time PCR in 
bronchial swabs collected from the natural seeder and 27.6% (8/29) of contact gilts. A 
high percentage (41%) of cranio-ventral consolidation and moderate (grade 2) 
microscopic lesions were observed in the lungs of the natural seeder. For the contact gilts, 
55.2% (16/29) and 3.4% (1/29) showed either mild (≤10%) or moderate (11-20%) gross 
lung lesions suggestive of M. hyopneumoniae infection. Regarding microscopic scores, 
31.0% (9/29), 24.1% (7/29), 17.2% (5/29), and 13.8% (4/29) of contact gilts showed mild 
(grade 1), moderate (grade 2), severe (grade 3), or very severe (grade 4) lung lesions, 
respectively.  
2.4.2.3 Transmission assessment  
Based on the diagnostic criterion, 27% (8/29) of contact gilts became M. 
hyopneumoniae positive during the 8-week period. The transmission rate per week (ꞵ) 
was 0.73 with a 95% highest posterior density credible interval of 0.31-1.61. At 6 and 8 
wpc, the M. hyopneumoniae incidence rate was 0.006 and 0.035, respectively. The Rn 
value (95% confidence) was estimated as 5.84 (2.48-12.88), implying that a mean of 5.84 
secondary infections resulted from one naturally infected gilt at 8 weeks post-
introduction in the group of naïve gilts.  
2.5  Discussion 
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This study was designed to evaluate the transmission and detection of M. 
hyopneumoniae based on the introduction of one naturally infected gilt to a naïve 
population. Our results showed that the estimated transmission rate (ꞵ) and eight-week 
adjusted reproductive ratio (Rn) of M. hyopneumoniae was 0.73 new infected gilts/gilt-
week and 5.84 secondary infected gilts/8 weeks, respectively, with a secondary infection 
initially detected at 6 wpc to the natural seeder. The ability to detect a recent M. 
hyopneumoniae introduction was largely influenced by the sample type and the length of 
time pigs were comingled prior to sampling.  
The spread of M. hyopneumoniae has been described to be slow and persistent in 
swine populations. Assessment of M. hyopneumoniae transmission rate and duration of 
shedding has been primarily investigated in experimental trials. Nevertheless, the 
transmission and detection of M. hyopneumoniae may differ under natural conditions, 
which is important to consider when making inferences to the field. Compared to 
previous investigations (Meyns et al., 2004, Villarreal et al., 2011, Roos et al., 2016), the 
ꞵ and the Rn estimated in this study differed numerically. Several factors, including but 
not limited to, the type of infection, strain and infectious dose utilized, time and 
proportion of seeders that are introduced, and contact period, can directly influence the 
transmission parameters. Numerical differences in transmission and infection dynamics 
have been shown to occur between strains of high and low virulence (Meyns et al., 2004; 
Villarreal et al., 2011). Moreover, a long contact period can theoretically increase ꞵ in a 
susceptible population as the likelihood of effective contacts is often high under such 
conditions. In this study, a moderately virulent M. hyopneumoniae strain (232) was 
utilized during the development of the natural seeder. Although infectivity of the natural 
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seeder was unknown, a low relative bacterial load was detected at the time of initial 
introduction. Regardless, the ꞵ and the Rn estimated in this study were higher when 
compared to other M. hyopneumoniae transmission studies (Meyns et al., 2004; 
Villarrreal et al., 2011). Such differences could have resulted from the longer contact 
period that was employed in this study (i.e. 8 wpc versus 6 weeks by Meyns et al. (2004) 
and Villarreal et al. (2011)), resulting in the ability to detect an exponential increase in M. 
hyopneumoniae prevalence which specifically occurred between 6 and 8 wpc. It is 
important to mention that a single replicate was conducted in this study, thus resulting in 
a large confidence interval for the estimated transmission parameters.  
Exposure to M. hyopneumoniae and consequently the establishment of infection 
and disease development are often dependent upon several potential risk factors, 
including managerial, environmental, and husbandry-related (Stärk, 2000; Maes et al., 
2008). While differences in farm practices exist, it is important to consider what risk 
factors could influence the contact of a susceptible individual or population to the 
pathogen. In this study, gilts were housed in a single pen located in a mechanically 
ventilated and filtered air space. Compared to the field, different conditions related to 
ventilation, herd size, stocking density, and housing, etc., are likely to be employed, 
which may alter the transmission rate of M. hyopneumoniae.  
Due the slow nature of infection and tropism towards respiratory cilium, 
differences in diagnostic sensitivity for M. hyopneumoniae detection given the sample 
type and stage of infection have been well-described (Sorensen et al., 1997; Sibila et al., 
2009; Pieters et al., 2017, Sponheim et al., 2020). In the present study, the sensitivity for 
ante-mortem detection of M. hyopneumoniae in the natural seeder was greatest in deep 
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tracheal catheters, followed by laryngeal swabs and then blood samples. Regarding the 
contact gilts, a difference in the time-to-detection between deep tracheal catheters and 
blood samples was observed. Moreover, poor sensitivity for M. hyopneumoniae detection 
at the pen-level using oral fluids was apparent, as all samples were negative regardless of 
the presence of at least one infected gilt in the population. These findings are in 
agreement with previous studies that concluded M. hyopneumoniae detection to be 
dependent on sample type (Pieters et al., 2017, Sponheim et al., 2020). Veterinarians and 
producers rely heavily on diagnostic results to guide health and management decisions. 
Based on the conditions of this study, false negative results were more likely to occur in 
blood samples and oral fluids compared to deep tracheal catheters and laryngeal swabs. 
Therefore, these results suggest that there is a high likelihood of missing a recent M. 
hyopneumoniae introduction when considering the common surveillance protocols that 
are currently employed in the swine industry. Further research is needed to provide 
insight on detection probabilities given certain sampling strategies and isolation lengths 
for the surveillance of M. hyopneumoniae.  
2.6  Conclusions 
In this study, secondary M. hyopneumoniae infections post-introduction of a 
naturally exposed gilt were initially detected at 6 wpc. Moreover, the ability to detect M. 
hyopneumoniae was greatly influenced by the sample type and the length of contact, with 
blood samples and oral fluids leading to high likelihood of missed infections for eight 
weeks. Information generated in this study can be utilized by veterinarians and producers 
to modify current surveillance protocols with different ante-mortem sample types and/or 
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sample timing to increase sensitivity for M. hyopneumoniae detection, thus aiding in the 












Figure 2.1 Graphical representation of study design and timeline   
    =Experimentally infected gilt;      =Natural seeder;      =Naïve contact gilt. 





Table 2.1 Mycoplasma hyopneumoniae detection and seroconversion during the natural transmission phase (0 to 8 weeks post-
contact) 
wpc 0 1 2 4 6 8 
Sample DTC LS DTC LS DTC LS DTC LS DTC LS DTC LS BS 
              
Natural seeder 36.24 35.71 30.07 39.71 30.09 30.96 34.38 - 26.04 29.70 29.81 32.19 25.74 
              
Contact gilt(s) 1 - - - - - - - - - - - - 26.30 
2 - - - - - - - - - - - - - 
3 - - - - - - - - 28.61 33.36 23.89 34.00 22.62 
4 - - - - - - - - - - 29.50 - 23.53 
5 - - - - - - - - - - 38.60 - 39.51 
6 - - - - - - - - - - 34.45 - 35.37 
7 - - - - - - - - - - - - - 
8 - - - - - - - - - - - - - 
9 - - - - - - - - - - - - - 
10 - - - - - - - - - - - - - 
11 - - - - - - - - - - - - - 
12 - - - - - - - - - - - - - 
13 - - - - - - - - - - - - - 
14 - - - - - - - - - - - - - 
15 - - - - - - - - - - - - 38.07 
16 - - - - - - - - - - - - - 
17 - - - - - - - - - - - - - 
18 - - - - - - - - - - - - - 
19 - - - - - - - - - - - - - 
20 - - - - - - - - - - - - - 
21 - - - - - - - - - - - - - 
22 - - - - - - - - - - - - - 
23 - - - - - - - - - - - - - 
24 - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - 
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26 - - - - - - - - - - - - - 
27 - - - - - - - - - - - - 37.47 
28 - - - - - - - - - - 38.92 - 38.69 
29 - - - - - - - - - - - - - 
% contact gilts positive 0% (0/29) 0% (0/29) 0% (0/29) 0% (0/29) 3.4% (1/29) 27.6% (8/29) 
              
Oral fluid (pen) (-) (-) (-) (-) (-) (-) 
 
wpc=weeks post-contact. DTC=deep tracheal catheter sample. LS=laryngeal swab. BS=bronchial swab. Real time-PCR results are presented as negative (-) or 
positive (Ct value <40) for M. hyopneumoniae. Percent of positive contact gilts at each sampling event (0-8wpc) were based on parallel diagnostic interpretation 
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Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in 
significant respiratory challenges in the swine industry worldwide. Vaccination for M. 
hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity 
in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae 
vaccination on transmission across different populations has been minimally investigated. 
The aim of this pilot study was to evaluate the effect of multiple vaccinations on M. 
hyopneumoniae infection, transmission, and genetic variability in infected and 
susceptible gilt populations. Thirty-two naïve gilts were allocated to four treatment 
groups: 1) Vaccinated seeder (VS); 2) Non-vaccinated seeder (NVS); 3) Vaccinated 
contact (VC); and 4) Non-vaccinated contact (NVC). At 5, 7, and 9 weeks of age, all gilts 
selected to be vaccinated received a commercial M. hyopneumoniae bacterin for a total of 
3 doses. At 11 weeks of age, VS and NVS gilts were inoculated with M. hyopneumoniae 
to become seeders. At 28 days post-inoculation (dpi), VS and NVS gilts were 
individually relocated to clean experimental rooms, where they were placed in contact 
with one age-matched VC or NVC gilt (1:1 ratio) for 14 days. Blood samples, tracheal 
samples, bronchial swabs, and lung lesions were collected and/or evaluated for M. 
hyopneumoniae infection. In this study, a three-dose vaccination strategy against M. 
hyopneumoniae significantly reduced bacterial load in seeder gilts. Furthermore, a 
numerical reduction in M. hyopneumoniae lung lesions at 28 dpi was observed in VS 
gilts. All VC gilts in the VS:VC treatment group pairing remained Mycoplasma 
hyopneumoniae negative, compared to other groups in which 1-2 transmission events 
occurred per treatment group. Results from this investigation provide insight in the 
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potential impact of multiple vaccinations on reducing M. hyopneumoniae transmission 
and infection. Further research encompassing vaccination of gilt groups in field settings 
is necessary to validate findings.  
3.2 Introduction 
Infections caused by Mycoplasma hyopneumoniae (M. hyopneumoniae), the 
etiologic agent of enzootic pneumonia in swine (Maré and Switzer, 1965; Goodwin et al., 
1965) continue to inflict significant respiratory health challenges in pigs worldwide. 
Clinical manifestations of M. hyopneumoniae infection are usually evidenced in the 
grower-finisher phase of production. However, infection at the sow herd is known to be 
influential on disease outcome in market pigs (Fano et al., 2007; Sibila et al., 2007a). 
Transmission of M. hyopneumoniae primarily occurs horizontally through nose-to-nose 
contact between infected and susceptible pigs (Morris et al., 1995) and through dam-to-
piglet contact during the lactation period (Calsamiglia et al., 2000a; Pieters et al., 2014). 
Indirect transmission via aerosol has been considered to play an important role in the 
spread of M. hyopneumoniae, as studies have shown the likelihood of disease 
introduction to decrease as distance from positive herds increased (Goodwin, 1985; Jorsal 
and Thomsen, 1988). In addition, M. hyopneumoniae detection and viability in air 
samples collected up to 9.2 km from an infected herd has been described (Otake et al., 
2010). Previous studies have also shown a reduction in the risk of M. hyopneumoniae 
transmission via entry of personnel and fomites by implementing biosecurity measures 
between infected and naïve herds (Batista et al., 2004; Pitkin et al., 2011).  
To mitigate M. hyopneumoniae infection, parity segregation, all-in/all-out flow 
management, antibiotic treatments, vaccinations, among others have been implemented in 
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the field (Maes et al., 2007). Vaccinations against M. hyopneumoniae are commonly 
utilized in the field to decrease clinical severity of infection and associated disease (Sibila 
et al., 2007a; Haesebrouck et al., 2004). In commercial herds, M. hyopneumoniae 
vaccines are often administered to piglets prior to/during weaning, or to incoming 
replacement gilts (Haesebrouck et al., 2004; Garza-Moreno et al., 2018). The routine 
vaccination of sows against M. hyopneumoniae is minimally practiced (Garza-Moreno et 
al., 2018). However, sow vaccination is implemented to aid in herd stability or disease 
elimination (Bargen et al., 2004; Holst et al., 2015). Although complete protection is not 
achieved (Meyns et al., 2006; Pieters et al., 2010; Villarreal et al., 2011) , vaccination 
efficacy has been demonstrated by an improvement in average daily gain (2-8%) and feed 
efficiency (2-5%), reduction in bacterial load within the respiratory tract, decrease in 
clinical signs and lung lesions, and lower M. hyopneumoniae herd prevalence, especially 
when two doses are administered (Sibila et al., 2007a; Maes et al., 1998; Maes et al., 
1999; Baccaro et al., 2006). Such beneficial outcomes may lead to a reduction in 
transmission among infected and susceptible pigs and influence the overall infection 
pressure at herd level.  
Intra-herd dynamics of M. hyopneumoniae infection in sow herds are greatly 
influenced by the health status of gilts and the recipient sows. In endemically infected 
herds, the maintenance of infection has been suggested to occur from the consistent 
influx of negative replacement gilts, thus creating the opportunity for the pathogen to be 
transmitted between infected recipient sows and negative gilts, further propagating 
infection within the herd (Dee, 1996; Takeuti et al., 2017b; Pieters and Maes et al. 2019). 
Therefore, gilt acclimation strategies have been utilized to promote herd stabilization and 
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cessation of bacterial shedding during lactation. Several vaccination strategies with 
varied vaccine timing and number of doses have been applied in gilt acclimation 
programs (Garza-Moreno et al., 2018). However, the efficacy and potential application of 
vaccination across different dam populations remain poorly understood, especially in 
conditions where vaccination can be applied to the incoming and/or recipient dams to 
promote decreased shedding of the bacterium. In infected or naïve populations, the 
impact of one or two-dose vaccinations on M. hyopneumoniae infection and/or 
transmission has been evaluated. With one vaccination, a numerical reduction in M. 
hyopneumoniae adjusted reproductive number was estimated for vaccinated groups 
(Rn=0.71-2.38) compared to non-vaccinated groups (Rn=0.56-3.51, p>0.05, Meyns et al., 
2006; Villarreal et al., 2011).  Moreover, Pieters et al. (2010) demonstrated that the 
vaccination of sentinels with two doses prior to housing with infected pigs did not 
prevent colonization, as the proportion of infected sentinels did not change based on 
vaccination status. Indirectly, this concept has been investigated by assessing 
colonization of piglets born to vaccinated dams (Sibila et al., 2008; Garza-Moreno et al., 
2019). Nevertheless, the combined effect of multiple vaccinations in both populations 
(infected and susceptible pigs) has been minimally evaluated. Therefore, the aim of this 
pilot study was to assess the effect of multiple vaccinations on M. hyopneumoniae 
infection, transmission, and genetic variability in infected and susceptible gilt 
populations.  
3.3  Materials and methods 
3.3.1  Ethics statement  
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All animals were cared for according to protocols designed specifically for the 
project, which were approved by the Institutional Animal Care and Use Committee of the 
University of Minnesota. Handling of the M. hyopneumoniae inoculum was performed 
following protocols approved by the Institutional Biosafety Committee at the University 
of Minnesota.  
3.3.2  Animals and housing 
Thirty-two commercial gilts were randomly selected at 3 weeks of age from a M. 
hyopneumoniae and Porcine Reproductive and Respiratory Syndrome Virus negative 
wean-to-finish farm, which was sourced from a negative sow herd. Prior to the study, 
their negative M. hyopneumoniae status was confirmed via the absence of seropositivity 
and detection of M. hyopneumoniae genetic material using blood and tracheal samples, 
respectively. Six weeks into the study, gilts were transported and housed in a filtered, 
accredited biosafety level-2 isolation unit at the University of Minnesota.  
3.3.3  Experimental design  
A graphic representation of the study experimental design is provided in Figure 
3.1. The study consisted of three phases, namely: vaccination, seeder development, and 
transmission period. Gilts were randomly allocated to four treatment groups at the 
beginning of the vaccination phase (n=8/group): 1) Vaccinated seeder (VS); 2) Non-
vaccinated seeder (NVS); 3) Vaccinated contact (VC); and 4) Non-vaccinated contact 
(NVC). Once allocated, gilts were housed by treatment group. The sample size for each 
group was calculated based on the ability to detect significant differences in number of 
infections between seeder and susceptible contact gilts across treatment groups using a 
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0.05 error rate.  A brief description of the research procedures conducted during each 
study phase is presented as follows:  
3.3.3.1 Vaccination  
Gilts to be vaccinated (VS n=8; VC n=8) received 1 mL of a commercial M. 
hyopneumoniae bacterin intramuscularly (Ingelvac Mycoflex®, Boehringer Ingelheim 
Vetmedica GmbH, used under license) at 5, 7, and 9 weeks of age, for a total of three 
doses. At each vaccination event, blood samples were collected from all gilts in the study 
(n=32) to evaluate seroconversion.  
3.3.3.2 Seeder development 
For the purpose of this study, seeders were defined as gilts that were 
experimentally inoculated with M. hyopneumoniae and were confirmed infected at 28 
days post-inoculation (dpi). At 11 weeks of age, eight VS and eight NVS gilts were 
transported to the isolation unit three days prior to inoculation for acclimation, and were 
housed in separate rooms by vaccination status. Tracheal samples and blood samples 
were collected from each gilt at arrival. At 0 dpi, gilts (n=16) were intra-tracheally 
inoculated with 10 mL of a lung homogenate containing 1x105 CCU/mL of M. 
hyopneumoniae strain 232 (obtained from Iowa State University, Ames, IA, USA), which 
has been fully sequenced (Minion et al., 2004) and known to be of moderate virulence. 
The inoculation technique was performed without sedation and as described by Gomes 
Neto et al. (2014), using a sterile rubber urinary catheter (Covidien, Mansfield, MA, 
USA). At 28 dpi, tracheal samples and blood samples were collected from each 
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individual gilt to confirm infection. Afterwards, seeder gilts (VS & NVS) were relocated 
to clean, individual experimental rooms (n=16).  
3.3.3.3 Transmission period 
Each transmission period consisted of 14 days of contact between one seeder and 
one susceptible contact gilt for a total of four replicates per seeder-to-contact treatment 
group pairing. In doing so, the following seeder-to-contact treatment group pairings were 
evaluated: NVS:NVC, VS:NVC, NVS:VC, VS:VC. Seeder gilts were housed with 
susceptible contact gilts at peak of shedding (Roos et al., 2016). Prior to introduction with 
seeders, tracheal samples and blood samples were collected from each contact gilt to 
confirm negative M. hyopneumoniae infection status. To assess M. hyopneumoniae 
transmission, tracheal samples and blood samples were collected from all gilts at 7 and 
14 days post-contact (dpc). Throughout the sampling, investigators were blinded as to 
which gilts were the seeders or the contacts.  
3.3.4  Sample collection and processing 
Tracheal samples were collected via intra-tracheal introduction of a sterile rubber 
urinary catheter (Covidien, Mansfield, MA, USA) with the aid of a laryngoscope and 
mouth speculum (Fablet et al., 2010). Tracheal secretions were obtained by washing tip 
of catheter with 500uL of phosphate-buffered saline. Sampling equipment was 
disinfected with 70% ethanol and rinsed with water between gilts to avoid sample cross-
contamination. Blood samples were collected from the jugular vein of each gilt using 
vacutainer tubes (BD Vacutainer® Blood Collection Tubes, Franklin Lakes, NJ, USA) 
and sterile needles (BD Vacutainer® Blood Collection Needles, Franklin Lakes, NJ, 
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USA). Prior to processing, tracheal samples and blood samples were stored at -20oC and  
4oC, respectively.   
At euthanasia, the percentage of anatomic lung lobe lesions was recorded by a 
masked investigator, as previously described by Pointon et al. (1999). Additionally, a 
bronchial swab was collected from each gilt by sampling a bronchiole of grossly affected, 
apical or cardiac lung lobes with a sterile rayon swab (BBL CultureSwabTM, Copan Italia 
Spa, Brescia, Italy). If macroscopic lesions were absent, a pre-determined lobe was 
sampled. Microscopic lung lesions were scored based on a modified scoring system from 
Calsamiglia et al. (2000b), which included a 5th score when large parabronchial lymphoid 
nodules were present with absence of alveolar inflammation.    
Samples were individually tested at the University of Minnesota Veterinary 
Diagnostic Laboratory. Detection of the microorganism in tracheal samples and bronchial 
swabs was achieved using a M. hyopneumoniae real-time PCR (Strait et al., 2008). 
Furthermore, the presence of M. hyopneumoniae antibodies was assessed using a 
blocking ELISA (Dako Corporation, Carpinteria, CA, USA) in serum samples.  
3.3.5  Diagnostic interpretation 
Tracheal samples and bronchial swabs were considered positive with a <40 Ct 
value. At the end of the transmission period, gilts were determined to be M. 
hyopneumoniae positive based on a parallel interpretation of diagnostic results. This 
diagnostic criterion was used to evaluate M. hyopneumoniae transmission across 
treatment groups.  Using a blocking ELISA, seroconversion was evaluated by comparing 
the sample optical density (OD) value to the OD value of the buffer control, yielding a 
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percent inhibition value. A sample was considered positive if the percent inhibition of the 
sample was ≤ 50% of the buffer control.   
3.3.6  Multiple-locus Variable Number tandem repeat Analysis (MLVA) 
To assess the effect of M. hyopneumoniae vaccination on genetic variability, 
MLVA was performed on M. hyopneumoniae positive tracheal samples and bronchial 
swabs to obtain a Variable Number Tandem Repeat (VNTR) type. The procedure was 
performed as described by Dos Santos et al. (2015), in which two loci, namely P97 and 
P146, were targeted. For assay verification, the M. hyopneumoniae ATCC 25095 
reference strain was used as a positive control. The number of tandem repeats within each 
loci was estimated using a bioinformatics analytic software (BioNumerics, version 7.1, 
Applied Maths, Austin, TX, USA). Similar parameters described by Dos Santos et al. 
[36] were used for the determination of VNTR types.  
3.3.7  Data analysis  
Differences in relative bacterial load (Ct values) and seroconversion based on 
seeder gilt vaccination status were assessed using a Welch two sample t-test. 
Furthermore, a non-parametric Mann-Whitney t-test and Pearson’s Chi-square test were 
utilized to compare percent of lung lesion and microscopic scores based on vaccination 
status of seeders and contact gilts, respectively. Diagnostic results, including those 
negative for detection of M. hyopneumoniae or antibodies, were included in the analysis. 
Results with a p-value <0.05 were deemed significant. By employing a maximum 
likelihood estimator (Bertram et al., 2018), the daily force of infection (λ) for each 
treatment group pairing was estimated. The probability that the contact gilts became 
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infected was calculated using the equation (Bertram et al., 2018): Prob (transmission)= 
1-e- λT, in which a constant force of infection (λ) was assumed and T is the time (days) at 
which a contact gilt became M. hyopneumoniae positive during the transmission period.  
In addition, incidence rate based on pig-days at risk was calculated using epitools 
package (R Core Team, 2019). Data analyses were performed using R 3.6.1 (R Core 
Team, 2019).  
3.4  Results 
3.4.1  Vaccination 
All gilts were serologically negative at the beginning of the vaccination phase. A 
decrease in percent inhibition was identified at the second vaccination in all VS and VC 
gilts (68.74±10.66) compared to NVS and NVC gilts (84.50±6.32; p<0.01; Figure 3.2), 
indicating a higher antibody response in vaccinated gilts compared to non-vaccinated 
gilts. Antibodies were detected in all tested VS and VC gilts at the third vaccination, 
while NVS and NVC gilts remained negative. Lower percent inhibition values were 
detected in VS and VC gilts (23.72±8.72) compared to NVS and NVC gilts (88.47±5.99; 
p<0.01) at the end of the vaccination phase, suggesting a high antibody response. 
Mycoplasma hyopneumoniae antibodies could not be evaluated in one VS gilt due to 
insufficient sample volume.  
3.4.2  Seeder development  
Prior to inoculation (0 dpi), all VS and NVS gilts (n=16 total) were M. 
hyopneumoniae negative by real-time PCR. Mycoplasma hyopneumoniae seroconversion 
was confirmed in all tested VS gilts, whereas all tested NVS gilts remained seronegative. 
68 
 
For two VS gilts, the presence of M. hyopneumoniae antibodies could not be evaluated 
due to insufficient sample volume.  
At the end of the seeder development phase (28 dpi), M. hyopneumoniae was 
detected by PCR in 75% (6/8) and 100% (8/8) of the VS (29.71±6.8) and NVS 
(26.17±3.3) gilts, respectively. Differences in Mycoplasma hyopneumoniae Ct values 
between groups were not statistically significant, regardless of seeder vaccination status 
(p=0.25). Moreover, 100% (8/8) and 87.5% (7/8) of the VS and NVS gilts were 
seropositive for the microorganism. Lower percent inhibition values were detected in VS 
gilts (6.65±9.2) compared to NVS gilts (39.17±9.8; p<0.01).  
3.4.3  Transmission period  
3.4.3.1 Detection of M. hyopneumoniae genetic material  
Antemortem detection of M. hyopneumoniae in seeders and their corresponding 
contact gilts based on treatment group pairing is shown in Figure 3.3. Upon arrival to the 
isolation facility, all contact gilts (NVC and VC) were negative for M. hyopneumoniae. 
Throughout the transmission period, all NVS gilts in the NVS:NVC treatment group 
pairing were M. hyopneumoniae positive. At 14 dpc, 25% (1/4) of the NVC gilts became 
infected with M. hyopneumoniae.  
In comparison, all VS gilts in the VS:NVC treatment group pairing became M. 
hyopneumoniae positive at the transmission period (Figure 3.3B). Additionally, half (2/4) 
of the NVC gilts became infected with M. hyopneumoniae at the end of the transmission 
period. For the NVS:VC treatment group pairing, all NVS gilts were M. hyopneumoniae 
positive throughout the transmission period. At 7 dpc, 25% (1/4) of the VC gilts became 
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infected with M. hyopneumoniae, which remained positive at 14 dpc (Figure 3.3C). In the 
VS:VC treatment group pairing, all VS and VC gilts were M. hyopneumoniae positive 
and negative, respectively, throughout the transmission period (Figure 3.3D). 
Based on seeder vaccination status, a reduction in M. hyopneumoniae relative 
bacterial load was detected in VS gilts (33.22±4.8) compared to NVS gilts (27.45±2.8; 
p=0.01) at 7 dpc. Moreover, significant differences in M. hyopneumoniae Ct values were 
also detected in VS gilts (34.97±4.1) and NVS gilts (30.05±3.1; p=0.02) at the end of the 
transmission period (14 dpc).  
Post-euthanasia, 100% (16/16) of the seeders were M. hyopneumoniae positive in 
bronchial swabs regardless of vaccination status. Mean Ct values were numerically 
higher for VS gilts (29.3±6.1) compared to NVS gilts (27.8±2.9; p=0.58). Table 3.1 
provides postmortem diagnostic results in contact gilts. At 14 dpc, two NVC gilts in the 
VS:NVC treatment group pairing became M. hyopneumoniae positive in bronchial swab. 
Moreover, one NVC gilt and one VC gilt in the VS:NVC and VS:VC treatment group 
pairings was M. hyopneumoniae positive in bronchial swabs. All bronchial swabs 
collected from VC gilts in the VS:VC treatment group pairing remained negative (Table 
3.1). Cycle threshold values for all PCR testing are provided in Table S1. 
3.4.3.2 Detection of M. hyopneumoniae antibodies 
Antibody levels were higher for VS gilts compared NVS gilts at 0 and 7 dpc 
(p<0.01). At 14 dpc, 75% (6/8) and 100% (8/8) of the VS and NVS gilts, respectively, 
were seropositive. Differences in antibody levels between the two groups were not 
significant (p=0.19) at 14 dpc. At 0 dpc, all VC gilts (8/8) were seropositive. Over time, a 
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numerical decrease in the number of positive samples was detected in VC gilts, in which 
87.5% (7/8) and 62.5% (5/8) remained seropositive at 7 and 14 dpc, respectively. All 
NVC gilts (8/8) remained seronegative for M. hyopneumoniae throughout the entire 
transmission period. For detailed information regarding antibody levels for all gilts, refer 
to Table S1. 
3.4.3.3 Lung lesion scores 
Mean macroscopic lung lesions (%) were numerically lower in VS gilts 
(2.87±2.99) compared to NVS gilts (4.12±5.14, p=0.78). Differences in microscopic 
scores based on seeder gilt vaccination status were not detected (p=0.80). Macroscopic 
and microscopic lung lesions were not identified in any of the VC gilts from the VS:VC 
treatment group pairing, compared to the other pairings (Table 3.1).  
3.4.3.4 Transmission parameters 
Numerical differences in λ and incidence rate were estimated between the four 
treatment group pairings (Table 3.2). The mean rate at which a contact gilt became 
infected per day and incidence rate was lowest when both seeder and contact gilts were 
vaccinated.   
3.4.4 MLVA typing  
At total of 66 M. hyopneumoniae PCR positive samples were processed for 
MLVA typing. Throughout the entire study, a single MLVA type (14-21) was detected in 
both VS and NVS gilts and their corresponding M. hyopneumoniae positive, contact gilts 
(data not shown).  
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3.5  Discussion 
The effect of multiple vaccinations on M. hyopneumoniae infection, transmission, 
and genetic variability in infected and susceptible gilt populations was assessed in this 
study. Administration of three vaccine doses prior to M. hyopneumoniae infection 
resulted in the development and persistence of antibodies throughout the study, as well as 
the reduction in M. hyopneumoniae relative bacterial load in vaccinated seeder gilts 
compared to non-vaccinated seeder gilts. Although complete protection to M. 
hyopneumoniae infection was not evident, vaccination of both seeders and their 
corresponding contact gilts numerically reduced the rate at which contact gilts became 
infected, resulting in a lack of transmission during a two-week contact period. In 
comparison, at least one contact gilt became infected with M. hyopneumoniae for the 
remaining treatment group pairings. Differences in M. hyopneumoniae genetic variability 
due to vaccination were not observed as a single VNTR type was detected in all M. 
hyopneumoniae positive samples in this study.  
It has been suggested that M. hyopneumoniae transmission may be reduced using 
vaccines due to the known effects that this control strategy has on lowering bacterial 
loads (Meyns et al., 2008; Pieters et al., 2010; Villarreal et al., 2011). To best address this 
question, three vaccine doses were administered to induce a strong immune response and 
reduce M. hyopneumoniae colonization, thus optimal conditions for inhibition of 
transmission could be achieved. In the present study, a reduction in M. hyopneumoniae 
relative bacterial load was evident in vaccinated seeder gilts compared to non-vaccinated 
seeder gilts. This finding is supportive of previous work in which similar results have 
been observed (Baccaro et al., 2006; Sibila et al., 2007a; Woolley et al., 2014). Vaccine 
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timing and the number of doses are thought to be influential for reducing M. 
hyopneumoniae infection. Traditionally, the maximum beneficial effects for M. 
hyopneumoniae control post-vaccination have been proposed to occur several months 
after implementation (Haesebrouck et al., 2004). However, studies specifically looking at 
this topic are scarce. In this study, the timing of the first vaccination occurred six weeks 
prior to inoculation, thus allowing enough time for gilts to develop a strong immune 
response to reduce clinical severity and disease outcomes. The onset of serological 
response was detected four weeks after the first vaccination, which has been similarly 
observed (Meyns et al., 2006; Baccaro et al., 2006). Mycoplasma hyopneumoniae 
antibodies were still detected in a majority of the vaccinated contact gilts eight weeks 
after the initial vaccination. Antibody levels have been detected until 1-3 months after 
vaccination (Maes et al., 2008). It is important to note that differences in onset and 
duration of serological response post-vaccination can vary among different vaccine 
preparations and number of vaccine doses. Garza-Moreno et al. (2019) observed 
numerical differences in the proportion of seropositive piglets and percentage of antigen 
inhibition within a sample when multiple vaccinations were administered to gilts, 
favoring four versus two doses.   
In this study, lung lesion severity was not statistically different in vaccinated and 
non-vaccinated seeder or contact gilts. Reduction in lung lesions and cough severity, 
along with improved growth performance, are considered main outcomes from M. 
hyopneumoniae vaccination and have been used to measure vaccine efficacy (Sibila et al., 
2007a; Maes et al., 1998). Differences in seeder lung lesion scores in this study were 
likely not observed due to a large variation in lesion severity within treatment groups, 
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thus reducing statistical power. Moreover, findings from a systematic review have 
described several factors, including study duration and M. hyopneumoniae strain, to be 
influential for the variation in disease severity (Garcia-Morante et al., 2017). In this 
study, lung lesion severity in seeders was assessed at 42 dpi, a time between when peak 
macroscopic lung lesions (28 dpi) and increased variation in lung lesion severity (56 dpi) 
have been described (Garcia-Morante et al., 2017). In other studies, similar or minimal 
differences in lung lesion scores between non-vaccinated and vaccinated pigs have also 
been suggested to result from an inadequate immune response prior to exposure (Maes et 
al., 1999; Sibila et la., 2007a) or a short infectious period. In the field, significant 
differences in macroscopic lung lesions between non-vaccinated and vaccinated (one or 
two-dose) pigs were not evident until 25 weeks of age, in which pigs were colonized with 
M. hyopneumoniae as early as three weeks of age (Sibila et al., 2007a). Under 
experimental conditions, Meyns et al. (2006) identified significant differences in lung 
lesions between non-vaccinated and vaccinated (one-dose) seeders and their naïve contact 
gilts at six weeks post-infection. In the mentioned investigations, a highly virulent strain 
and greater infectious dose were utilized, as opposed to this study in which a strain of 
moderate virulence and the minimal infectious dose (Marois et al., 2010) to induce 
pneumonia were employed. Pertaining to the contact gilts, the duration of transmission 
was likely too short (14 days) to observe significant differences in macroscopic lung 
lesions.  
The ability to measure differences in transmission as the result of an intervention 
can be challenging to achieve as there can be several factors that affect the transmission 
dynamics. Within a population, the number of susceptible and infectious individuals, the 
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number of contacts, and the probability of transmission are all factors that can influence 
the transmission of a pathogen. Moreover, additional variables including but not limited 
to the stocking density, frequency of contacts, and population size etc., should be 
considered when designing a study. For this investigation, an experimental model that 
incorporated a 1:1 seeder-to-contact ratio was employed. By conducting this experiment 
in such manner, other factors that could be present under field conditions were minimized 
to provide further insight into the potential causality of vaccination on transmission. 
Moreover, the M. hyopneumoniae vaccine was administered to seeders, susceptible 
contact gilts, or both to best understand the full effect of this intervention on 
transmission. Another advantage of conducting an experimental model that incorporates a 
1:1 seeder-to-contact ratio is that the likelihood of infection from other individuals can be 
ruled out, thus making the probability of infection more robust (Velthuis et al., 2002). 
Under experimental conditions, Pieters et al. (2010) and Meyns et al. (2006) evaluated 
the effect of  two or one vaccine doses on M. hyopneumoniae transmission in only 
contact gilts or in both seeders and contacts, respectively. Moreover, Villarreal et al. 
(2011) investigated this topic further by conducting a field study, in which one vaccine 
dose was administered to seeders. Across all studies, significant differences in M. 
hyopneumoniae transmission based on vaccination were not observed. However, a 
numerical reduction in the M. hyopneumoniae adjusted reproductive number was 
estimated in vaccinated versus non-vaccinated groups (Meyns et al., 2006; Villarreal et 
al., 2011). The results of this present study are in agreement with previous studies that 
concluded vaccination to numerically reduce M. hyopneumoniae transmission during a 
short period of time. In this study, statistical differences were not found due to the 
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overlapping confidence levels across groups. However, small variations in the rate at 
which susceptible pigs become infected (λ) may theoretically result in major differences 
in the total number of infected gilts when longer time periods are considered. Considering 
different intra-herd dynamics in the field, there may be some biological importance to 
vaccinate  incoming naive and infected recipient populations, such that the infectious 
pressure in the herd may be reduced over time. Routine administration of multiple 
vaccine doses in a population may not be as appealing when considering additional costs 
associated with labor and the vaccine product. However, the application for this study 
would be most advantageous in M. hyopneumoniae positive herds that undergo gilt 
acclimation or an elimination program, in which case the benefits may outweigh the costs 
associated with the intervention, if herd stability is achieved earlier. Further research 
encompassing larger populations across longer time periods is necessary to confirm such 
findings and potential implications. Additional research directed at improving vaccine 
efficacy would also be desired to aid in M. hyopneumoniae prevention. 
Statistical differences in M. hyopneumoniae transmission were not observed, 
potentially due to a short contact period. Since the experimental period was much shorter 
than the infectious period and considering the relatively slow onset of M. hyopneumoniae 
infection, the influence of vaccination on transmission could be greater under conditions 
in which the effect of the intervention can be fully observed. Moreover, additional 
replicates would have helped to validate the findings in this study, such that the 
likelihood of these events occurring due to random chance could be ruled out. In addition, 
the two VS gilts that remained M. hyopneumoniae negative until 14 dpc may have altered 
the overall number of NVC gilts that became M. hyopneumoniae positive throughout the 
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transmission period. Such finding could have resulted from the intrinsic variability of 
sampling live pigs, the inoculation method, or a delay in onset of infection due to the 
vaccination. In this study, intra-tracheal inoculation was performed as this method has 
been described to result in a high proportion of pigs infected with M. hyopneumoniae, as 
well as significant lung lesions compared to other exposure routes (Garcia-Morante et al., 
2016). However, variability in M. hyopneumoniae infection models has been described, 
even in conditions when the same strain and dose are utilized (Garcia-Morante et al., 
2016).  
Intra-herd genetic diversity of M. hyopneumoniae has been identified, primarily 
through the utilization of MLVA (Betlach et al., 2019). However, drivers for M. 
hyopneumoniae genetic diversity continue to remain unknown. Michiels et al. (2017) 
demonstrated a  higher diversity of M. hyopneumoniae variants in bronchoalveolar lavage 
fluid collected from slaughter pigs sourced from vaccinated herds. Nevertheless, 
additional reseach is needed to further clarify this topic. It has been hypothesized that 
genomic modifications on surface adhesin proteins may result from pressures influencing 
host-pathogen adaptations (Zhang et al., 1995). The M. hyopneumoniae genome has 
several surface proteins that have been described to be involved in cilia adhesion and/or 
antigenic variation (Zhang et al., 1995; Assunção et al., 2005b). Antigenic variation is a 
defense mechanism in which pathogens can undergo alterations in immunogenic epitopes 
that help facilitate evasion of the host immune system and promote persistence of 
infection (van der Woude and Baumler, 2004). One of the targeted loci in MLVA, 
namely P97, is a M. hyopneumoniae surface adhesin that has been suggested to undergo 
antigenic variation (Zhang et al., 1995). To help investigate this hypothesis, the genetic 
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diversity of M. hyopneumoniae post-vaccination was investigated. Under the conditions 
of this study, a single VNTR type was detected in vaccinated and non-vaccinated gilts, 
which is the same VNTR type as the strain utilized in the study. The detection of a single 
VNTR type suggests that vaccine administration did not influence the genetic diversity of 
this pathogen post-infection. However, we can not rule out other factors, such as timing, 
that might have contributed to a limited genetic diversity. Additional reseach is needed to 
understand potential drivers for M. hyopneumoniae diversity, especially considering the 
very short duration of this study.   
3.6 Conclusions 
In conclusion, the present study showed that a three-dose vaccination strategy 
against M. hyopneumoniae significantly reduced the relative bacterial load in infected 
gilts. Furthermore, a numerical reduction in M. hyopneumoniae transmission and lung 
lesions in susceptible contact gilts was observed across seeder-to-contact pairings with 
differing vaccine dynamics, favoring conditions when both seeders and their 
corresponding contact gilts were vaccinated. This study provides additional insight on the 
potential application of multi-dose vaccination strategies for M. hyopneumoniae control 














Each circle corresponds to an individual gilt and is color-coded based on treatment. Each box represents an 





 =VS (Vaccinated seeder).        =NVS (Non-vaccinated seeder).       =VC (Vaccinated contact).      





Figure 3.2 Mycoplasma hyopneumoniae seroconversion based on gilt vaccination status 
and timing   
Grey and white colors correspond to non-vaccinated or vaccinated gilts, respectively. Different superscripts 





Figure 3.3 Detection of Mycoplasma hyopneumoniae in seeders and their corresponding 
contact gilts based on treatment group pairing 
Treatment: VS (Vaccinated seeder); NVS (Non-vaccinated seeder); VC (Vaccinated contact); NVC (Non-
vaccinated contact). For each pairing, treatment of seeder is stated first followed by treatment of contact 
gilt. Each circle corresponds to an individual gilt. Black circles represent detection of M. hyopneumoniae in 
tracheal samples. In each black circle, Ct values for M. hyopneumoniae detection are present. White circles 




Table 3.1 Summary of Mycoplasma hyopneumoniae diagnostic results in contact gilts based on corresponding seeder-to-contact 









Treatment: VS (Vaccinated seeder); NVS (Non-vaccinated seeder); VC (Vaccinated contact); NVC (Non-vaccinated contact). For each pairing, treatment of 
seeder is stated first followed by contact gilt treatment. *Data represents diagnostics results and lung lesions of only contact gilts (NVC and VC), which is 
presented according to seeder-to-contact treatment group pairing.  
 
   Contact gilts (n=4/group) 
Treatment group pairing*  NVS: NVC VS: NVC NVS: VC VS: VC 
Tracheal samples Number positive  1 1 1 0 
Ct value(s) 
 
33.15 31.06 33.32 --- 
Bronchial swabs Number positive  1 2 1 0 
Ct value(s) 
 
29.49 36.52, 38.01 35.13 --- 
Macroscopic lung lesions Mean score (min, max) 
 
0.50 (0,2) 1.50 (0,3) 1.00 (0,3) 0 (0,0)  
Microscopic lung lesions Mean score (min, max) 1.75 (0,4)  3.25 (0,5) 2.25 (0,5)  0 (0,0) 
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Table 3.2 Mycoplasma hyopneumoniae transmission parameters based on  
seeder-to-contact treatment group pairing 
Treatment group pairing Force of infection (95% CI) Incidence rate (95% CI) 
NVS: NVC 0.021 (0.001, 0.091) 0.018 (0.005, 0.099) 
VS: NVC 0.050 (0.009, 0.159) 0.034 (0.004, 0.129) 
NVS: VC 0.022 (0.001, 0.097) 0.020 (0.002, 0.114) 
VS: VC 2.30E-11 (0.000, 0.034) 0.000 (0.000, 0.066) 
Treatment: VS (Vaccinated seeder); NVS (Non-vaccinated seeder); VC (Vaccinated contact);  


















Chapter 4: Effect of antibiotic treatment on Mycoplasma 
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4.1  Summary 
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes significant economic 
losses in the swine industry. Antibiotics with activity against Mycoplasma spp. are 
employed for disease mitigation and pathogen elimination. However, veterinarians are 
often challenged with the detection of M. hyopneumoniae by PCR after antibiotic 
treatment, thus raising the question whether the bacterium is still infectious. The 
objective of this study was to evaluate the effect of tulathromycin treatment on M. 
hyopneumoniae detection and infectious potential during the acute and chronic phases of 
infection. For each infection phase, one age-matched naïve gilt was placed in contact 
with one M. hyopneumoniae infected gilt that was either treated with tulathromycin, 
treated and vaccinated, or non-treated, for 14 days. Four replicates per treatment group 
were performed for each infection phase. A numerical reduction in relative bacterial load 
was observed in acutely, treated gilts compared to non-treated gilts. The rate at which 
naïve gilts became infected with M. hyopneumoniae was numerically reduced when co-
housed with treated, acutely infected gilts compared to those housed with non-treated, 
infected gilts. During the chronic infection phase, M. hyopneumoniae was detected by 
PCR in more than 50% of treated infected gilts and persisted for up to three months post-
treatment. In addition, transmission was not detected in all treatment groups, however, 
the possibility that the pathogen was infectious could not be completely ruled out.  
Further research focused on assessing M. hyopneumoniae detection and viability post-
treatment is necessary to guide control and elimination efforts. 
4.2 Introduction  
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Infections caused by Mycoplasma hyopneumoniae (M. hyopneumoniae) are 
prevalent worldwide and continue to be one of the most significant bacterial health 
concerns in swine (Pieters and Maes, 2019). The effect of M. hyopneumoniae infection is 
mainly tangible in altered finishing production parameters, such as decreased average 
daily gain and poor feed efficiency. It has been suggested that controlling M. 
hyopneumoniae infection during the finishing period is primarily influenced by the health 
status of the sourcing breeding herd(s), as weaned piglets are often colonized from 
shedding dams (Calsamiglia and Pijoan, 2000a). After colonization, M. hyopneumoniae 
can be shed for a long period of time (at least up to 214 days post-inoculation; Pieters et 
al., 2009), resulting in infection and clinical disease during the grower-finisher phase. 
Moreover, a positive correlation between M. hyopneumoniae prevalence at weaning and 
disease severity at marketing has been shown (Fano et al., 2007). To combat M. 
hyopneumoniae infection, control and elimination strategies are often implemented in the 
field. Changes in management practices, vaccination, and antibiotic treatment are used, 
alone or in combination, to mitigate the detrimental effects of M. hyopneumoniae 
infection in swine herds. In practice, antibiotic treatments with activity against 
Mycoplasma spp. are commonly employed for disease mitigation, as well as for pathogen 
elimination (Maes et al., 2018).  
Tulathromycin is a macrolide highly effective for treating respiratory disease in 
swine (Nutsch et al., 2005)  and is commonly employed for M. hyopneumoniae disease 
elimination in the field (Holst et al., 2015). Moreover, immune-modulatory properties of 
tulathromycin have been shown to aid in the resolution of inflammation in the context of 
respiratory disease in pigs (Duquette et al., 2015). Following antibiotic treatment, it is 
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essential to accurately assess changes in disease outcome and evaluate pathogen 
clearance to guide health and management decisions. However, this can be challenging as 
M. hyopneumoniae genetic material has been detected by PCR up to 189 days post-
inoculation, even after tulathromycin treatment has been applied (Painter et al., 2012). 
Persistence of M. hyopneumoniae detection post-treatment with other classes of 
antibiotics, such as tetracyclines and fluoroquinolones, has also been described (Thacker 
et al., 2006; Le Carrou et al., 2006). Although antibiotic resistance of M. hyopneumoniae 
has been shown to a limited extent (Maes et al., 2020b), the continued detection of 
genetic material by PCR in treated pigs could result from its slow degradation and 
clearance by immune cells and mechanical defenses of the respiratory system. However, 
the infectious potential of the bacterium under these conditions has not been investigated.  
In addition, the significantly low sensitivity of bacterial culture for M. 
hyopneumoniae is a limitation to evaluate pathogen viability in vitro (Sibila et al., 2009). 
Thus, the research question of the infectious capability of M. hyopneumoniae genetic 
material detected by PCR in treated pigs remains to be answered. Therefore, the objective 
of this study was to evaluate the effect of tulathromycin on M. hyopneumoniae detection 
and infectious potential during the acute and chronic phases of infection using an in vivo 
transmission model.   
4.3       Materials and methods 
4.3.1 Animals, housing, and ethics statement 
A total of 48 gilts from a M. hyopneumoniae and Porcine Reproductive and 
Respiratory Syndrome Virus negative farrow-to-finish farm were randomly selected and 
ear-tagged at three weeks of age. Negative status of the farm was based on several years 
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of herd diagnostic results, the absence of M. hyopneumoniae detection by PCR and 
seroconversion, and the lack of suggestive clinical signs. Three days prior to inoculation, 
24 3-week-old gilts were transported to experimental isolation units at the University of 
Minnesota and housed together by treatment group for acclimation. An additional 24 
naïve gilt were later incorporated in the study and housed with infected gilts during the 
acute and chronic infection phases. At arrival, gilts were confirmed negative to M. 
hyopneumoniae by the absence of clinical signs suggestive of infection, lack of pathogen 
detection in tracheal secretions, and lack of seroconversion to the bacterium. All gilts 
were cared for according to project-specific protocols approved by the Institutional 
Animal Care and Use Committee, University of Minnesota. Use and handling of the M. 
hyopneumoniae inoculum were approved by the Institutional Biosafety Committee of the 
University of Minnesota.  
4.3.2 Experimental design 
The experimental design of this study is depicted in Figure 4.1. The study was 
composed of four phases: 1) Infection development, 2) Transmission assessment during 
acute infection phase, 3) Transmission assessment during chronic infection phase, and 4) 
Persistence post-treatment. Gilts were randomly allocated to one of seven treatment 
groups: Naïve contact gilts for acute and chronic infection phases (n=24); Acutely 
infected, control (AC, n=4); Acutely infected and treated (AT, n=4); Acutely infected, 
treated and vaccinated (ATV, n=4); Chronically infected, control (CC, n=4); Chronically 
infected and treated (CT, n=4); and Chronically infected, treated and vaccinated (CTV, 
n=4). Power analysis was not employed to estimate sample size, as this was a pilot study. 
Once allocated, gilts were housed together by treatment group until the start of the 
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transmission experiments. Briefly, two sets of transmission experiments, one during acute 
infection (28-42 days post-inoculation (dpi)) and one during chronic infection (85-99 
dpi), were performed in this study. For each transmission experiment, one age-matched 
naïve gilt was housed with one M. hyopneumoniae infected gilt that was either non-
treated (AC or CC), treated (AT or CT), or vaccinated and treated (ATV or CTV) for 14 
days. Four replicates per treatment group per phase of infection were performed. All gilts 
that took part in the acute infection phase were euthanized at the end of the transmission 
experiment (42 dpi). For the chronic infection phase, all gilts were euthanized at the end 
of the transmission experiment (99 dpi), except for CT and CTV gilts that were M. 
hyopneumoniae positive by PCR and did not transmit the bacterium to their 
corresponding naive gilt. The persistence of M. hyopneumoniae detection post-treatment 
was assessed in the remaining CT and CTV gilts for an additional 56 days (99-155 dpi). 
Research procedures conducted during each study phase are described below: 
4.3.3  Study phases 
4.3.3.1  Infection development  
Gilts in AC, AT, ATV, CC, CT, and CTV groups were intratracheally inoculated 
(Gomes Neto et al., 2014) with ten mL of a lung homogenate containing 1x105 color-
changing units (CCU)/mL of M. hyopneumoniae strain 232 (purchased from Iowa State 
University, Ames, IA, USA) for two consecutive days. Tracheal secretions were collected 
at 14 dpi from inoculated gilts to confirm infection via PCR detection of M. 
hyopneumoniae. Following inoculation, AC, AT, and ATV gilts were housed by 
treatment group until 28 dpi to develop acute M. hyopneumoniae infection. Chronically 
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infected, control (CC), CT, and CTV gilts were housed by treatment group for a longer 
period (until 85 dpi) to become chronically infected.   
4.3.3.2 Transmission assessment during acute infection phase 
At 8 and 18 dpi, AT and ATV gilts (n=4/group) were intramuscularly treated with 
2.5 mg/kg of tulathromycin (Draxxin®, Zoetis, Parsippany, NJ, USA). Additionally, ATV 
gilts (n=4) were intramuscularly vaccinated with 2mL of a commercial M. 
hyopneumoniae bacterin (Respisure®, Zoetis, Parsippany, NJ, USA) at 0 and 23 dpi. At 
28 dpi, gilts in AC, ACT, and ATV groups (n=4/group) were individually relocated to 
clean, experimental rooms, where they were housed with one age-matched naive gilt for 
14 days. The naive gilts were placed in contact with AC, AT, and ATV gilts when peak 
of shedding has been shown under experimental conditions (Roos et al., 2016). Prior to 
housing with infected gilts, the health status of naive gilts was confirmed via the absence 
of M. hyopneumoniae detection by PCR and the absence of seroconversion. To assess M. 
hyopneumoniae transmission, tracheal secretions were collected at 0, 11, and 14 days 
post-contact (dpc) from all gilts. In addition, blood samples were collected at 0 and 14 
dpc. Throughout sampling, investigators were masked as to which gilts were infected or 
naïve. At the end of the transmission experiment, all gilts were euthanized by barbiturate 
overdose, followed by the scoring of lung lesions and the collection of bronchial swabs 
and lung tissue. 
4.3.3.3  Transmission assessment during chronic infection phase 
During the chronic infection phase, CT and CTV gilts (n=4/group) were 
intramuscularly treated with 2.5 mg/kg of tulathromycin at 64 and 74 dpi. Furthermore, 
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CTV gilts were vaccinated with 2mL of the commercial M. hyopneumoniae bacterin at 0 
and 23 dpi. Before the transmission experiment, one CC gilt and one CTV gilt died due to 
secondary bacterial infections. At 85 dpi, all remaining CC, CT, and CTV gilts (n=10 
total) were relocated to individual, clean, experimental rooms and each gilt was housed 
with one naive gilt for 14 days. Tracheal secretions were collected at 0, 11, and 14 dpc, 
along with the collection of blood samples at the beginning and end of the transmission 
experiment. All gilts were euthanized at the end of the transmission experiment, except 
for CT and CTV gilts that were M. hyopneumoniae positive by PCR and did not transmit 
the bacterium to their corresponding naive gilt. Post-euthanasia, lung lesions were scored 
along with the collection of bronchial swabs and lung tissue.  
4.3.3.4  Persistence of Mycoplasma hyopneumoniae post-treatment  
To evaluate the persistence of M. hyopneumoniae detection by PCR post-
treatment, a fourth phase of the study was conducted. Based on a diagnostic criterion, CT 
and CTV gilts that were M. hyopneumoniae PCR positive at the end of the chronic 
transmission experiment and did not transmit the bacterium to their corresponding naive 
gilt were kept for an additional 56 days (i.e., 99 to 155 dpi) for further sampling. A lack 
of transmission to naïve gilts was determined based on the absence of M. hyopneumoniae 
detection in the respective gilt by PCR. During the additional 56 days, CT and CTV gilts 
were housed by treatment group and tracheal secretions were collected from each gilt at 
approximately every two weeks. At 155 dpi, gilts were humanely euthanized. In addition, 
lung lesions were scored and bronchial swabs were collected in all gilts.  
4.3.4 Sample collection and processing 
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Tracheal secretions were collected as described by Fablet et al. (2010) by 
introducing a sterile rubber urinary catheter (Covidien, Mansfield, MA, USA) into the 
mouth of each gilt until the trachea was reached. The tip of the catheter was placed into a 
sterile 5mL tube containing 500uL of phosphate-buffered saline and was vortexed. To 
minimize cross-contamination, handling equipment was disinfected with 70% ethanol 
and rinsed with water between each sampled gilt.  Blood samples were collected from the 
jugular vein using vacutainer tubes (BD Vacutainer® Blood Collection Tubes, Franklin 
Lakes, NJ, USA) and sterile needles (BD Vacutainer® Blood Collection Needles, 
Franklin Lakes, NJ, USA). Tracheal secretions and blood samples were stored at -20oC 
and  4oC, respectively, until processed.  
At euthanasia, macroscopic lung lesions were assessed and scored based on the 
percent of anatomical lobe affected (Pointon et al., 1999). Lesions were scored in all gilts 
by the same investigator, who was blinded to the pig identification throughout the 
process. Bronchial swabs were collected from each gilt by inserting a sterile rayon swab 
(BBL CultureSwabTM, Copan Italia Spa, Brescia, Italy) into the main airways of the 
apical or cardiac lung lobe when macroscopic lung lesions were evident. If lesions were 
absent, a pre-determined area was systematically sampled. To evaluate microscopic 
lesions, lung samples were collected in the transitional area when lesions were evident. or 
in a consistent anatomical area if absent and submitted for histopathologic evaluation. 
Tissue samples were fixed in 10% formalin, stained with hematoxylin and eosin, and 
scored. The scoring system employed was slightly modified from Calsamiglia et al. 
(2000b), as the addition of a 5th score was included when lesions characterized by large 
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parabronchial lymphoid nodules with an absence of alveolar inflammation were present. 
Furthermore, a section of lung tissue was collected for bacterial aerobic culture.  
All samples were submitted for individual testing at the University of Minnesota 
Veterinary Diagnostic Laboratory. Species-specific real-time PCR (Strait et al., 2008) 
was performed on tracheal secretions and bronchial samples to detect M. hyopneumoniae 
genetic material. For seroconversion assessment, blood samples were processed for 
serum separation and M. hyopneumoniae ELISA (Idexx, Westbrook, Maine, USA) was 
performed on serum.  
4.3.5 Diagnostic interpretation 
Samples were considered positive for detection of M. hyopneumoniae when a Ct 
value was <37. Samples with Ct values ranging from 37 to 40 were considered suspect 
for M. hyopneumoniae. Parallel interpretation of PCR results was used to determine the 
infection status of gilts, thus if either the tracheal secretions or bronchial swabs resulted 
PCR positive, the gilt was considered infected. For M. hyopneumoniae ELISA, samples 
were considered positive with a ≥ 0.4 S/P value.    
4.3.6 Data analysis  
Differences in M. hyopneumoniae detection and disease severity were assessed 
using descriptive statistics. Mean Ct values were calculated using positive samples and 
were used to assess the relative bacterial load within the lower respiratory tract. To assess 
differences in M. hyopneumoniae transmission, the daily force of infection (λ), the rate at 
which naive pigs became infected per day, was calculated using maximum likelihood 
estimator (Bertram et al., 2018). Throughout the transmission period, the probability of 
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infection was calculated using the equation, Prob (transmission)= 1-e- λT (Bertram et al., 
2018) and λ was assumed to be constant. The incidence rate based on pig-days at risk was 
calculated by employing ‘epitools’ package (R Core Team, 2019). Data analyses were 
conducted using R 3.6.1 (R Core Team, 2019).  
4.4 Results 
4.4.1  Infection development  
Upon arrival to the isolation facility, gilts tested negative for M. hyopneumoniae 
infection. At 14 dpi, all inoculated gilts (24/24) were confirmed M. hyopneumoniae 
positive with a mean Ct value of 24.1±2.9. A numerical decrease in the mean M. 
hyopneumoniae relative bacterial load was detected in AT gilts (26.1±2.3) at 14 dpi 
compared to AC gilts (22.6±1.6). In ATV gilts, a numerical reduction in the mean 
relative bacterial load (24.8±2.4) was also identified to a lesser degree.  
4.4.2 Transmission assessment during acute infection phase 
All infected gilts remained positive for M. hyopneumoniae throughout the 
transmission experiment, regardless of receiving tulathromycin treatment. At 0, 11, and 
14 dpc, a numerical reduction in relative bacterial load was evident in AT gilts compared 
to other treatment groups (Table 4.1). At 0 dpc, a delay in seroconversion was detected in 
AT gilts compared to gilts in other treatment groups (Table 4.1).  
Prior to housing with infected gilts, all naive gilts were negative for M. 
hyopneumoniae. At the end of the transmission experiment (14 dpc), 50% (2/4) of the 
naïve gilts that were housed with AC gilts became M. hyopneumoniae positive, in which 
one gilt was initially positive at 11 dpc (Table 4.1).  In comparison, all naive gilts that 
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were housed with AT gilts remained negative during the transmission experiment. For the 
naive gilts housed with ATV gilts, 25% (1/4) became M. hyopneumoniae positive at 11 
dpc.  
Postmortem diagnostic results for AC, AT, and ATV gilts and their corresponding 
naive gilts, including macroscopic lung lesions and histopathologic scores, are presented 
in Table 2. Briefly, a numerical reduction in lung lesions (17.6-16.1%) was observed in 
AT and ATV gilts compared to AC gilts. Moreover, the relative bacterial load of M. 
hyopneumoniae was numerically lower in bronchial swabs collected from AT (21.4±1.7) 
and ATV (21.3±0.51) gilts compared to AC gilts (19.4±0.8; Table 4.2). Similar mean 
bronchial swab Ct values for AT and ATV gilts were detected. Using aerobic culture, 
Glaesserella parasuis was grown from lung tissue from one AC, one AT, and one naïve 
gilt (Table 4.2). 
4.4.3  Transmission assessment during chronic infection phase 
At the beginning and end of the transmission experiment, all CC gilts were 
positive for M. hyopneumoniae by PCR via tracheal secretions (Table 1). For the 
remaining treatment groups, M. hyopneumoniae was detected in a subset of the CT and 
CTV gilts (Table 1). At 14 dpc, a numerical reduction in the mean M. hyopneumoniae 
relative bacterial load was detected in CT gilts (32.2±0.7) and CTV gilts (30.4 ±5.2) 
compared to CC gilts (29.2 ±4.4). Fifty percent (2/4) of CT gilts and 33% (1/3) of CTV 
gilts were negative for M. hyopneumoniae in tracheal secretions at the end of the 
transmission experiment (Table 1). Mycoplasma hyopneumoniae antibodies were 




At 0 dpc, all naïve gilts were confirmed negative for M. hyopneumoniae. 
Throughout the transmission experiment, all naive gilts remained M. hyopneumoniae 
negative by PCR, regardless of treatment group. Therefore, the two CT gilts and one 
CTV gilt that were M. hyopneumoniae negative and all CC gilts were euthanized at this 
time point.  
On postmortem examination, macroscopic and microscopic lung lesions were 
absent in all CC, CT, and CTV gilts. All bronchial swabs obtained from the CC gilts were 
positive for M. hyopneumoniae, with a mean Ct value of 29.6±0.9 (data not shown). 
Except for one CT gilt (28.7 Ct value), bronchial swabs collected from the euthanized CT 
and CTV gilts were negative for M. hyopneumoniae. Moreover, bacterial growth was not 
observed via aerobic culture in lung tissue of all gilts. 
4.4.4 Persistence of M. hyopneumoniae  
Two CT and two CTV gilts were sampled for an additional 56 days as they 
remained M. hyopneumoniae positive by PCR at 99 dpi but did not transmit the pathogen 
to their corresponding naïve gilt. From 99 to 155 dpi, inconsistent detection of M. 
hyopneumoniae in tracheal secretions was observed in one CT and one CTV gilt (Table 
4.3). Mycoplasma hyopneumoniae was detected in one CT and one CTV gilt until 127 
and 155 dpi, respectively. At the end of the study, only two gilts (CT and CTV) remained 
M. hyopneumoniae positive based on parallel interpretation of PCR results. Macroscopic 
lung lesions (4 and 7%) were observed in one CT gilt and one CTV gilt, respectively, in 
which microscopic lesions suggestive of M. hyopneumoniae infection were only 
identified in the CT gilt (grade=5; data not shown). Bacterial growth was not observed 
from lung tissue postmortem.  
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4.4.5  Transmission parameters 
Numerical differences in the transmission parameters during the acute infection 
phase were calculated based on treatment group (Table 4.4). The mean rate at which a 
naive gilt became infected per day was highest when housed with AC gilts (λ=0.059; 
95% CI: 0.008,0.09), followed by ATV gilts (λ=0.021; 95% CI: 0.001, 0.094) and then 
AT gilts (λ=2.318E-11; 95% CI: NA, 0.034). Moreover, the mean incidence rate for AC 
gilts was 0.038, implying that during a 14-day period, there were 0.038 new M. 
hyopneumoniae infections per day at risk. In conditions where gilts were vaccinated 
and/or treated, the incidence rate numerically decreased (Table 4.4). During the chronic 
infection phase, M. hyopneumoniae transmission was not evident as all naive gilts 
remained negative.  
4.5 Discussion  
In this study, changes in M. hyopneumoniae detection and infectious potential 
were assessed after the administration of antibiotics and vaccination during the acute and 
chronic phases of infection. Therapeutic treatment of acute M. hyopneumoniae infection 
with tulathromycin resulted in a numerical reduction in relative bacterial load within the 
lower respiratory tract of infected gilts compared to their untreated counterparts. 
Macroscopic lung lesions were also numerically lower in treated, acutely infected gilts 
compared to non-treated gilts. Moreover, the rate at which naïve gilts became infected 
was numerically reduced when co-housed with infected gilts that received antibiotic 
treatment during the acute infection phase, as compared to infected gilts receiving no 
treatment. During the chronic infection phase, M. hyopneumoniae clearance was detected 
in over a quarter of the treated, infected gilts at 99 dpi. Inconsistent detection of M. 
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hyopneumoniae by PCR was also apparent for the treated, infected gilts, especially as the 
infection duration progressed. Differences in transmission rates based on treatment group 
could not be assessed during the chronic infection phase, as all naïve gilts remained M. 
hyopneumoniae negative, including those in contact with non-treated, infected gilts.   
Antibiotic treatment for M. hyopneumoniae infection has been well-described to 
decrease bacterial load in the respiratory tract and to decrease clinical severity, lung 
lesions, and mortality associated with the disease and secondary respiratory bacterial 
infections (reviewed by Maes et al., 2020b). In this study, a numerical reduction in 
bacterial load was observed when two tulathromycin treatments were administered during 
the acute or chronic infection phase. For acutely infected gilts that were treated and 
vaccinated, the effect of tulathromycin on M. hyopneumoniae bacterial load was observed 
to a lesser degree than in gilts that were only treated. One potential reason for a minimal 
reduction in bacterial load in treated and vaccinated, infected gilts was the vaccination 
timing, as this has been thought to be influential towards altering M. hyopneumoniae 
infection (Maes et al., 2008). Since gilts were vaccinated on the same day the inoculation 
took place, the vaccination timing likely did not provide a strong immune response to 
maximize the beneficial effects of the intervention with respect to the initial onset of 
infection. Treatment with tulathromycin also resulted in up to a 17.6% numerical 
reduction of macroscopic lung lesions during the acute infection phase, thus supporting 
previous results described by McKelvie et al. (2005) who showed a 8.4% reduction in 
lung lesions for tulathromycin-treated pigs. Beneficial effects of tulathromycin on health 
parameters may result as a direct effect of the antibiotics’ bacteriostatic properties to 
inhibit M. hyopneumoniae replication, as well as potential indirect elicited anti-
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inflammatory and immunomodulatory effects (Duquette et al., 2015). Compared to other 
antibiotic classes, studies have shown macrolides to induce neutrophil apoptosis and 
efferocytosis and inhibit several proinflammatory mediators using in vitro and in vivo 
models with PRRSv and Actinobacillus pleuropneumoniae (Duquette et al., 2015; Moges 
et al., 2018; Desmonts de Lamache et al., 2019). Anti-inflammatory and 
immunomodulatory effects of tulathromycin are perceived to be important for M. 
hyopneumoniae disease modulation, as lung lesion development is mainly attributed to 
the host immune response, resulting in an influx of proinflammatory cytokines and innate 
immune cells to infected tissue (Kuhnert and Jores, 2020). Nevertheless, additional 
research is needed to understand the anti-inflammatory and immunomodulatory effects of 
tulathromycin on M. hyopneumoniae infection and disease.  
Traditionally, antibiotic treatment for M. hyopneumoniae infection has been 
thought to decrease the transmission of this pathogen by hindering the bacterium’s ability 
to replicate in the respiratory tract, thus reducing the bacterial load that can be transmitted 
between individual pigs. However, the causal relationship between antibiotics and their 
effect on M. hyopneumoniae transmission has not been previously evaluated. Insight on 
whether antibiotics can alter pathogen transmission, and to what extent, is essential to 
optimize control and elimination efforts in the field. To best evaluate this relationship, a 
1:1 in vivo transmission model was conducted. In the present study, antibiotic treatment 
altered M. hyopneumoniae transmission during the acute infection phase, implying that 
new infections can still occur but at a lessened rate. Differences in M. hyopneumoniae 
transmission were not observed across the treatment groups due to wide and overlapping 
confidence intervals for the transmission parameters, which was likely attributed to the 
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small sample size. Moreover, differences in M. hyopneumoniae transmission during the 
chronic infection period could not be evaluated, as all naïve gilts remained negative until 
the end of the transmission experiment. Considering the long duration of shedding of M. 
hyopneumoniae, which can reach up to 214 days (Pieters et al., 2009), transmission 
parameters have been described to be slow and have only been estimated during the acute 
phase of infection (Meyns et al., 2004; Villarreal et al., 2011a; Betlach et al., 2020). 
Therefore, the lack of transmission evidenced during the chronic phase was likely the 
result of the short contact period (i.e., 2 weeks) and the potentially lower risk of pathogen 
spread, especially due to a potentially lower amount of M. hyopneumoniae that may be 
shed during this time of the infection. Additional research encompassing longer exposure 
periods and larger populations are warranted to confirm the findings of this study. 
In general, bacterial persistence post-treatment may result from biphasic killing 
kinetics or bacterial population heterogeneity in response to antibiotics due to the 
presence of ‘persister cells’, which are described as non- or slow- dividing cells that are 
not antibiotic-resistant but display a higher threshold of antibiotic susceptibility compared 
to other cells (Balban et al., 2019). Bacterial persistence can also be facilitated by several 
factors, including intrinsic or acquired antibiotic resistance, impairment of innate immune 
defenses, and pathogenic mechanisms to promote immune system evasion or tolerance 
(Balaban et al., 2019). For M. hyopneumoniae, the presence of persistent cells has been 
hypothesized, as pathogen detection by PCR, clinical signs, and/or lesions has been 
shown after the administration of antibiotics (Le Carrou et al., 2006; reviewed by Maes et 
al., 2020b). In this study, persistence of M. hyopneumoniae genetic material detection by 
PCR was shown by the lack of clearance for most infected gilts treated during the chronic 
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infection phase. Moreover, M. hyopneumoniae genetic material was detected by PCR up 
to approximately three months after receiving antibiotic treatment. However, pathogen 
transmission from persistently infected pigs was not shown. Drivers for M. 
hyopneumoniae persistence continue to remain unknown and are difficult to assess with 
the existing diagnostic techniques available. Studies have described antibiotic resistance 
(reviewed by Maes et al., 2020b), as well as potential biofilm formation for M. 
hyopneumoniae (Tassew, et al., 2017; Raymond et al., 2018). Moreover, the long 
generation time for M. hyopneumoniae  (i.e., 6-10 hours; Stemke and Robertson, 1990; 
Meyns et al., 2007) may contribute to bacterial persistence. Nevertheless, additional 
research is needed to understand the mechanisms that aid M. hyopneumoniae persistence, 
as well as to develop alternative methods to assess pathogen viability.  
During the chronic infection phase, it is important to mention that false negatives 
results were identified, as samples that resulted suspect or negative for M. 
hyopneumoniae detection by PCR originated from pigs deemed positive at later 
samplings. Such variation may be explained by intrinsic lack of consistency with 
sampling and low bacterial loads in the tracheal secretions. The implications of these 
findings are important to consider when interpreting diagnostic results in the field, 
especially when surveillance testing is conducted at the end of an elimination program, in 
which tulathromycin is often administered.  
4.6 Conclusions 
Based on the conditions of this study, the administration of tulathromycin 
modified M. hyopneumoniae infectious potential by numerically reducing the relative 
bacterial load and the rate of new infections for treated gilts compared to those non-
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treated during the acute phase of infection. Inconsistent detection, as well as persistence 
of M. hyopneumoniae detection by PCR post-treatment was evident during the chronic 
phase of infection. Further research focused on the effect of antibiotic treatment on M. 
hyopneumoniae viability and transmission and the development of alternative methods to 

















Table 4.1  In vivo Mycoplasma hyopneumoniae detection by PCR and seroconversion in 
infected gilts and corresponding naïve gilts  
 Infected gilts 
(% positive; evaluated/total) 
(Mean value ±SD)  
Corresponding naive gilts 
(% positive; evaluated/total) 
(Mean value ±SD) 
Mycoplasma hyopneumoniae detection by PCR  
 Treatment group Treatment group 
Acute   AC AT ATV AC AT ATV 








































































































Seroconversion to Mycoplasma hyopneumoniae by ELISA   
 Treatment group Treatment group 
Acute   AC AT ATV AC AT ATV 



































































Treatment group: AC (acutely infected, control); AT (acutely infected and treated); ATV (acutely infected, 
treated and vaccinated); CC (chronically infected, control); CT (chronically infected and treated); CTV 
(chronically infected, treated and vaccinated). dpc=days post-contact. For M. hyopneumoniae detection and 




 Table 4.2 Postmortem Mycoplasma hyopneumoniae detection by PCR, lung lesion severity (macroscopic and microscopic), and 
bacterial culture in acutely, infected gilts and corresponding naïve gilts 
  
Infected gilts  
(%; evaluated/total) 
Corresponding naïve gilts  
(%; evaluated/total) 
Treatment group Treatment group 
Macroscopic  
lung lesion score (%) 
  AC AT ATV AC AT ATV 
0  --- --- --- 100 (4/4) 50 (2/4) 25 (1/4) 
1-5  --- 50 (2/4) 25 (1/4) --- 25 (1/4) 75 (3/4) 
6-10  --- --- 25 (1/4) --- 25 (1/4) --- 
11-15  --- --- --- --- --- --- 
15-20  --- 25 (1/4) 50 (2/4) --- --- --- 
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Histopathologic score (0-5)            
0  --- 25 (1/4) --- 75 (3/4) 25 (1/4) 50 (2/4) 
1  --- --- 33 (1/3)* 25 (1/4) 25 (1/4) 50 (2/4) 
2  --- --- --- --- 25 (1/4) --- 
3  75 (3/4) --- 33 (1/3)* --- 25 (1/4) --- 
4  25 (1/4) 75 (3/4) 33 (1/3)* --- --- --- 
5  --- --- ---- --- --- --- 
        
Median  3 4 3 0 1.5 0.5 
        
Bronchial swab by PCR 
















Treatment group: AC (acutely infected, control); AT (acutely infected and treated); ATV (acutely infected, treated and vaccinated). *=histopathologic score was 
not evaluated in one of the four ATV pigs due to loss of tissue sample. SD=standard deviation. G. parasuis= Glaesserella parasuis.


















Table 4.3 Persistence of Mycoplasma hyopneumoniae detection by PCR during the 
chronic infection phase  
Treatment group: CT (chronically infected and treated); CTV (chronically infected, treated and vaccinated). 
For M. hyopneumoniae detection, values represent mean Ct by PCR. Positive PCR results are bolded in 









 Days post-inoculation 
Treatment 
group 
99 113 127 144 155 155* 
CT 31.44 26.58 29.1 39.56 39.59 --- 
CT 32.91 39.28 34.5 --- --- 28.72 
CTV 35.59 39.54 --- 34.97 --- --- 
CTV 25.18 30.23 34.9 32.83 34.01 --- 
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Table 4.4 Mycoplasma hyopneumoniae transmission parameters during the acute 
infection phase 
Treatment group: AC (acutely infected, control); AT (acute infected and treated); ATV (acutely infected, 
treated and vaccinated). CI=confidence interval. NA=not available
Treatment group Force of infection (95% CI) Incidence rate (95% CI) 
AC 0.059 (0.008, 0.090) 0.038 (0.004, 0.136) 
AT 2.318E-11 (NA, 0.034) 0.000 (0.000, 0.066) 





Figure 4.1 Study experimental design 
Treatment group: AC (acute, control); AT (acute, treated); ATV (acute, treated and vaccinated); CC (chronic, control); CT (chronic, treated); CTV (chronic, 
treated and vaccinated). Dashed lines correspond to infection development for the acute or chronic phase of infection, whereas solid lines indicate infection and 
transmission assessment for each phase. Black squares represent when M. hyopneumoniae bacterin was administered to ATV and CTV gilts (n=8). Black stars 
represent when tulathromycin was administered to AT, ATV, CT, and CTV gilts (n=16). Black circles indicate when naïve gilts were initially placed in contact 









Chapter 5: Characterization of circulating Mycoplasma hyopneumoniae 
variants in the Midwestern United States using Multiple-Locus Variable 













In the United States, Multiple-Locus Variable number tandem repeat Analysis 
(MLVA) and complete P146 gene sequence are commonly employed to molecularly 
characterize Mycoplasma hyopneumoniae from clinical samples. However, the 
comparison of MLVA and P146 sequencing and interpretation of assay results remains 
unclear. Therefore, the aim of this study was to characterize and compare M. 
hyopneumoniae variants in the Midwestern United States using MLVA and P146 gene 
sequencing. A total of 160 samples were analyzed for this investigation. Molecular 
techniques were compared for assay sensitivity, discriminatory power, and congruence. 
Epidemiological relationships in clustering of M. hyopneumoniae variants were evaluated 
by employing Principal Coordinate Analysis. Fair agreement (κ=0.34) in assay outcome 
was calculated between the two techniques. Ability to obtain a VNTR type or a P146 
sequence was dependent upon the relative bacterial load (i.e., Ct value) in the sample. 
The Simpson’s diversity index was higher for MLVA (D=0.899) than for P146 
sequencing (D=0.844). High congruence for the number of tandem repeats detected in 
the polyserine region of P146 was also obtained. Similar epidemiological inferences were 
generated from the two assays, as production flow explained most of the variation in the 
clustering of VNTR types and P146 sequences. Findings from this study highlighted 
differences in assay sensitivity and discriminatory power between the two molecular 
techniques. Nevertheless, both techniques showed a wide genetic diversity among M. 
hyopneumoniae variants, and similar epidemiological inferences were generated. Further 
research utilizing whole-genome sequencing should be conducted to evaluate the 
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presence of other variable areas within the genome that are unrepresented by MLVA and 
P146 sequencing.  
5.2  Introduction   
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the etiologic agent of 
enzootic pneumonia (Maré and Switzer, 1965; Goodwin et al., 1965), a chronic bacterial 
respiratory disease in swine known to result in major health and economic concerns. 
Enzootic pneumonia is characterized by a dry cough, reduced gain, and poor feed 
efficiency (Pointon et al., 1985; Straw et al., 1989). As a main contributor to the Porcine 
Respiratory Disease Complex, M. hyopneumoniae infections predispose pigs to 
secondary bacterial and viral pathogens, which further exacerbates respiratory disease 
challenges (Pieters and Maes, 2019).  
Intra-herd transmission of M. hyopneumoniae primarily occurs through direct 
contact between infected and susceptible pigs, including dam-to-piglet interaction. In sow 
herds, circulation of M. hyopneumoniae occurs among infected dams and incoming 
susceptible gilts, which is thought to maintain ongoing pathogen transmission due to the 
constant introduction of gilts year-round (Maes et al., 2018). Piglets are considered a 
secondary population that aid in pathogen transmission, as they are born free of the 
microorganism, but are later colonized from shedding dams during the lactation period 
(Calsamiglia and Pijoan, 2000a). Due to the long shedding duration of M. 
hyopneumoniae (Pieters et al., 2009), which can last up to 7 months, infected sow herds 
are considered the reservoir for M. hyopneumoniae for downstream grower-finisher herds 
(Fano et al., 2005; Maes et al., 2018). Nevertheless, inter-herd transmission of M. 
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hyopneumoniae via aerosol has been suspected to occur over long distances (Goodwin, 
1985).  
Pathogen origin can be inferred with an understanding of genetic relatedness 
between variants detected within and/or among herds, different geographic locations 
and/or time periods (Wang et al., 2015). As the cornerstone of molecular epidemiology, 
molecular characterization techniques should be accurate, feasible, reproducible, and with 
high discriminatory power (Wang et al., 2015). For M. hyopneumoniae, molecular 
characterization techniques are essential to link pathogen transmission between herds and 
support control and elimination efforts. Several M. hyopneumoniae molecular 
characterization techniques based on nucleic acid amplification, genome typing or 
sequencing have been described (reviewed by Betlach et al., 2019). In the United States, 
Multiple-Locus Variable number tandem repeat Analysis (MLVA) and sequencing of the 
complete P146 gene are two commonly employed techniques to characterize M. 
hyopneumoniae directly from clinical field samples or isolates. Given that Mycoplasma 
spp. genomes have numerous repetitive regions that undergo phase variation or 
recombination, MLVA typing (Vranckx et al., 2011) and P146 gene sequencing have 
been developed to target genomic areas with known highly variable regions and 
established bacterial adhesion functionality. Multiple MLVA techniques have been 
described using different loci (reviewed by Betlach et al., 2019). In the United States, M. 
hyopneumoniae MLVA typing has been standardized using two loci (Dos Santos et al., 
2015), namely P97 an adhesin protein, and P146, a surface protein with paralogous nature 
with P97 (Minion et al., 2004). Moreover, the gene that encodes for P146, has been 
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primarily sequenced as it contains many unique features, including two putative coiled-
coil domains and three variable repeat regions (Bogema et al., 2012).  
During recent years, there has been a pressing need to utilize M. hyopneumoniae 
molecular characterization techniques in the field for epidemiological investigations. 
However, there is limited information on the interpretation and comparison of MLVA 
and complete gene sequencing of P146, along with the epidemiological insight gained 
from the genomic analyses. Therefore, the aim of this study was to characterize and to 
compare M. hyopneumoniae variants in the Midwestern United States using MLVA and 
P146 gene sequencing.  
5.3 Materials and methods  
5.3.1  Clinical field samples  
A total of 160 clinical samples were conveniently collected between 2013 and 
2018 from 84 unique swine herds in five production systems that were predominately 
located in the Midwestern region of the United States. Samples, including laryngeal and 
bronchial swabs, and tracheal secretions, were submitted to the University of Minnesota 
Veterinary Diagnostic Laboratory (UMN-VDL) for routine diagnostic and/or surveillance 
purposes. Samples were processed and the genetic material was extracted and tested for 
M. hyopneumoniae real-time PCR (Strait et al., 2008), according to standardized 
protocols at the diagnostic laboratory. Samples were representative of M. hyopneumoniae 
cases within the Midwestern US swine industry as sampled herds were located in states 
that accounted for ~61% of the hog production inventory in the Midwest (Livestock 
Slaughter Annual Summary, USDA, NASS, 2018). Moreover, epidemiological 
information, including date, geographical location (i.e., state), production system, flow, 
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and stage were collected. In this study, a production flow is defined as a group of herds 
that share a common pig source and health status and is comprised of herds with different 
production stages (e.g., sow herd, nursery, finishing).   
5.3.2 Multiple-Locus Variable number tandem repeat Analysis     
The MLVA assay was attempted for the 160 samples, as described by Dos Santos 
et al. (2015). In addition, the M. hyopneumoniae ATCC 25095 reference strain was 
included to serve as a positive control. Briefly, the MLVA assay detected and quantified 
the number of tandem repeats for two loci, namely repeat region 1 (RR1) of P97 (Mhp 
138) and RR3 of P146 (Mhp 684). Genetic material for the two loci was amplified by 
performing a touchdown multiplex PCR modified from Vranckx et al. (2011). For the 
PCR, 0.2 μM of dye-labeled primers, 1X Qiagen Multiplex PCR Master Mix (Qiagen, 
CA, USA), and 2μL of DNA were combined for a final volume of 25 μL. PCR products 
were then analyzed by gel electrophoresis to confirm product amplification and later 
submitted for capillary electrophoresis. Data files from the capillary electrophoresis were 
imported into a bioinformatics analytic software (BioNumerics, version 7.1, Applied 
Maths, Austin, TX, USA), and computational parameters described by Dos Santos et al. 
(2015) were employed to assess fragment size and determine the number of tandem 
repeats for each locus. A minimum spanning tree was constructed to illustrate clustering 
based on categorical values of Variable Number Tandem Repeat (VNTR) type. Samples 
with an incomplete or partial VNTR type were removed from the clustering analysis.  
5.3.3  Complete gene sequencing of P146 
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P146 sequencing was conducted at the UMN-VDL using an in-house procedure 
that employed Sanger sequencing. Sequences from multiple Sanger runs were assembled 
and aligned using ClustalW to create a consensus sequence. Sequence analysis was 
performed using Geneious 10.2.3. For the analysis, sequences from five publicly 
available M. hyopneumoniae reference strains (i.e., strain 232 from United States –
Accession: AE017332.1; J strain from Brazil –Accession: AE017243.1; 7448 strain from 
Brazil –Accession:AE017244.1; 168 strain from China –Accession: CP002274.1; F7.2C 
strain from Belgium –Accession: DQ088147.1; and BQ14 strain from France –
Accession: AF279908) were included. Partial sequences were not included in the 
analysis. Sequences were aligned using MUSCLE algorithm with default settings, 
followed by translation of nucleotides to amino acids. A maximum likelihood 
phylogenetic tree was constructed for protein sequence alignments using RAxML v7.3.0 
(Stamatakis, 2006) based on 1,000 bootstrap replicates and default settings for JTT 
matrix-model. Microreact (Argimón et al., 2016) was employed to illustrate the 
phylogenetic tree.  
5.3.4 Comparison of molecular characterization techniques  
5.3.4.1 Assay performance  
Assay sensitivity was descriptively compared for MLVA and P146 sequencing. 
Logistic regression models were used to estimate the odds of obtaining a VNTR type or 
P146 sequence based on M. hyopneumoniae PCR Ct values. Agreement in assay outcome 
between the two molecular techniques was measured using Cohen’s kappa index. Level 
of agreement based on Kappa (κ) value was interpreted as follows: <0.00=poor; 0.00-
0.20=slight; 0.20-0.40=fair; 0.41-0.60=moderate; 0.61-0.80=substantial; 0.81-
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1.00=almost perfect (Landis and Koch, 1977). Data analyses were performed using R 
3.6.1 (R Core Team, 2019) and results with a p-value <0.05 were deemed significant.  
5.3.4.2 Discriminatory power and assay congruence for RR3 P146 serine repeats 
Discriminatory power was estimated by calculating Simpson’s index of diversity 
for MLVA using each targeted loci and their combination (i.e., VNTR type), as well as 
for P146 sequencing, with the Hunter-Gaston diversity index (Hunter and Gaston, 1988). 
The overall congruency and interchangeability between the two molecular techniques for 
the identification of serine repeats in RR3 P146 were estimated and compared by 
calculating the adjusted Rand (Hubert and Arabie, 1985) and adjusted Wallace 
coefficients (Pinto et al., 2008) using Comparing Partitions (Comparing Partitions, 
http://www.comparingpartitions.info/index.php?link=Home, accessed March 2, 2021). 
Adjusted Rand provides a measure of the overall agreement between two methods, 
whereas, the adjusted Wallace test provides information regarding directionality of 
agreement (Severiano et al., 2011). Therefore, inferences related to the probability that 
samples are classified together with a particular method based on their previous 
classification with a different method can be obtained.   
5.3.4.3 Epidemiological relationship 
Clustering of M. hyopneumoniae variants based on several epidemiological 
variables, including year, geographical location, and production flow, were explored by 
employing Principal Coordinates Analysis (PCoA) plots. For MLVA, PCoA plots were 
generated by Jaccard distance using phyloseq package (McMurdie and Holmes, 2013) in 
R (R Core Team). Similarly, PCoA plots were created for P146 sequences using the 
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percent difference in amino acids as a distance matrix. Clustering of sequences based on 
serine repeats was also evaluated. Cluster analysis was conducted using adonis and 
betadisper tests from the vegan package (Oksanen et al., 2020) in R. 
5.4 Results 
5.4.1 Assay performance    
The sensitivity of MLVA and P146 sequencing was 88.1% (141/160) and 78.7% 
(126/160), respectively, in which both a VNTR type and a P146 sequence were obtained 
for 75% (120/160) of the samples. Partial results were detected for 3.1% (5/160) and 10% 
(16/160) of the samples for MLVA and P146 sequencing, respectively. For MLVA, a 
VNTR type was not identified for 8.7% (14/160) of the samples. Similarly, a P146 
sequence was not obtained for 11.2% (18/160) of the samples. There was fair agreement 
(κ=0.34; 95% CI: 0.13-0.55) for assay outcome between the two molecular techniques. A 
significant relationship between Ct value and the ability to obtain a VNTR type or a P146 
sequence was observed (Figure 5.1). Since linearity assumption was not met, Ct values 
were divided into four groups: C1 (Ct values ≤20), C2 (Ct values 21-26), C3 (Ct values 
27-32), and C4 (Ct values ≥33). The estimated odds of obtaining a VNTR type was 
67.4%  and 97.3% lower for samples belonging to C3 (OR: 0.326; p-value=0.31) and C4 
(OR: 0.028; p-value<0.01) compared to C1 samples, respectively. Regarding P146 
sequencing, the estimated odds of obtaining a sequence was 85.2% lower for C3 samples 
than C1 samples (OR: 0.148; p-value=0.07). Odds for obtaining a sequence with C4 
samples was similar to those seen for VNTR type.  
5.4.2 Characterization of M. hyopneumoniae variants based on assay   
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Mycoplasma hyopneumoniae genetic diversity was evaluated in 120 samples 
using MLVA typing and P146 sequencing. Percentage of samples based on year of 
collection is as follows: 2013 (15.8%), 2014 (5.8%), 2015 (34.2%), 2016 (36.7%), 2017 
(4.2%), and 2018 (3.3%). The samples were collected from 71 unique herds of various 
production stages, including finishing (37.5%), gilt developing units (GDU; 26.7%), sow 
(23.3%), nursery (5.0%), and wean-to-finish sites (2.5%), with 5.0% of samples of 
unknown stage origin. Moreover, production flow information was obtained for most of 
the sampled herds, accounting for the evaluation of M. hyopneumoniae genetic diversity 
across 18 production flows.  
5.4.2.1 Multiple-Locus Variable number tandem repeat Analysis     
Thirty-four VNTR types were identified using MLVA (Figure 5.2). The most 
frequent VNTR types were: 13-17 (22.5%), 16-24 (20.0%), 19-19 (7.5%), and 3-15 
(6.7%). In this study, the number of tandem repeats for P97-RR1 and P146-RR3 ranged 
from two to 19, and from 12 to 27, respectively. Across the five production systems, four 
common VNTR types (i.e., 13-17, 16-18, 16-26, and 2-19) were identified, which 
accounted for 34% (41/120) of the samples collected. Within a single production flow, up 
to five VNTR types were identified (data not shown). At the herd-level, a single VNTR 
type was detected in a majority of herds (90.1%). For 9.8% (7/71) of the herds, two or 
three VNTR types were detected during one sampling event, in which VNTR types 
differed by no more than two tandem repeats in either one or both loci (data not shown). 
5.4.2.2 P146 sequencing  
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Mean percentage amino acid pairwise genetic distance for field sequences 
(n=120) was 2.9% (Table 5.1). Field sequences were more genetically similar to M. 
hyopneumoniae J strain from Brazil and strain 232 from the United States than strains 
7448, BQ14, 168, and F7.2C, which originated from Brazil, France, China, and Belgium, 
respectively (Table 5.1; Figure 5.3). Clustering of sequences based on serine repeat 
number was depicted in a phylogenetic tree (Figure 3) and supported through the 
employment of PCoA plots. In the Midwestern United States, serine repeat number 
accounted for 65.5% of the variation between the P146 sequences (R2=0.655; p-
value<0.01). Sequence variation was less associated with serine repeat number when 
sequences of greater genetic diversity (i.e., M. hyopneumoniae reference strains) were 
included (R2=0.231; p-value<0.01).  
5.4.2.3 Discriminatory power 
The Simpson’s diversity index for each loci and their combination for MLVA, as 
well as for P146 sequencing, is provided in Table 5.2. A significant difference in 
discriminatory power was calculated between MLVA (D=0.899) and P146 sequencing 
(D=0.844; p-value<0.01). 
5.4.2.4 Assay congruence for P146-RR3 serine repeats 
The number of serine repeats for P146-RR3 was compared between the two 
molecular techniques, resulting in high congruency, overall (ARI=0.910; CI: 0.835-
9.986; Table 5.2). Of the 120 samples, 6.6% (8/120) showed numerical differences in 
serine repeat count, ranging between 1 and 5 repeats. Directional agreement in serine 
repeats between MLVA and P146 sequence was evaluated by calculating the adjusted 
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Wallace coefficients. The value of AWMLVA P146 loci→Sequencing of 0.942 (CI: 0.890-0.994) 
was not significantly higher than the agreement measured by AWSequencing →MLVA P146 loci of 
0.880 (CI: 0.794-0.965; p=0.15; Table 5.2), indicating bidirectional correspondence.   
5.4.3 Epidemiological relationship 
Clustering of M. hyopneumoniae variants based on several epidemiological 
variables was explored by employing Principal Coordinates Analysis (PCoA) plots 
(Figure 5.4). Table 5.3 depicts variance in VNTR types and genetic distance for P146 
sequences based on production flow and stage, state, and year. Dissimilarities in VNTR 
type and P146 sequences were significantly associated with pig production flow, in 
which flow accounted for the highest amount of variation (Table 5.3). Variation in VNTR 
type and P146 sequences was minimally explained by production stage, state, and year.  
5.5 Discussion  
Mycoplasma hyopneumoniae variants in the Midwestern United States were 
characterized and compared using two commonly employed molecular techniques, 
MLVA and P146 sequencing. Molecular techniques were compared based on assay 
sensitivity, discriminatory power, and congruency. The ability to obtain a result varied 
between the two molecular techniques. However, assay outcome was dependent upon the 
relative bacterial load (i.e., Ct value) in the clinical sample, regardless of technique. A 
fair agreement in assay outcome was calculated, as opposed to a moderate or almost 
perfect agreement, which could have resulted from the higher number of partial or 
incomplete results obtained for P146 sequencing compared to MLVA. In this study, the 
molecular techniques were conducted in a parallel manner using the same genetic 
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material, thus reducing the presence of confounding variables. Nevertheless, variation 
could have resulted from the intrinsic differences in techniques, along with the 
corresponding primers utilized, or personnel performing the assay. 
Assay sensitivity and discriminatory power are two important features to consider 
for the employment of a molecular characterization technique, along with cost, feasibility 
and reproducibility. Molecular techniques with a high discriminatory power aid to further 
differentiate between variants. Throughout the literature, the characterization of M. 
hyopneumoniae variants and isolates has been shown to vary based on the technique 
employed. In this study, differences in discriminatory power between MLVA and P146 
sequencing were observed. Although the sequencing of the complete P146 gene has not 
been previously investigated prior to this study, sequencing of the polyserine encoding 
region of the P146 gene has been conducted and described to have a high discriminatory 
power (D=0.92; Mayor et al., 2007; Felde et al., 2018). Moreover, several studies have 
also described a high discriminatory power for MLVA techniques that incorporate the 
target of P146-RR3 (Vranckx et al.., 2011; Dos Santos et al., 2015; Felde et al., 2018).  
High congruency (ARI=0.910) and bidirectional agreement for the number of 
serine repeats in P146 was generated between the two molecular techniques. Therefore, 
both assays can be employed to characterize M. hyopneumoniae based on the polyserine 
encoding region of P146. Throughout the P146 gene, there are five highly diverse 
regions, which include three variable repeat regions and two putative coiled-coil 
domains. In this study, genetic variation across sequences was less associated with serine 
repeat number when M. hyopneumoniae reference strains were included. Therefore, a 
comprehensive review of the complete P146 gene is needed, especially with sequences of 
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high genetic diversity, to further characterize M. hyopneumoniae variants and identify 
regions of the gene that are influential towards genetic variation at the entire gene-level.    
To further characterize M. hyopneumoniae, whole-genome sequencing should be 
conducted to evaluate the presence of other variable areas within the genome that are 
unrepresented by MLVA and P146 sequencing. For other bacterial pathogens, whole-
genome sequencing is becoming a widely used technique for research and diagnostic 
purposes, in which isolates are predominately utilized (He, 2015). For M. 
hyopneumoniae, whole-genome sequencing has been employed for the molecular 
characterization of seven isolates (reviewed by Jarocki and Djordjevic, 2020). However, 
the fastidious nature of M. hyopneumoniae poses challenges with isolating the bacterium 
from clinical samples on a routine basis. Therefore, development and validation of 
procedures to ensure a high integrity and quantity of M. hyopneumoniae genetic material 
from clinical samples, while removing host or other bacterial and viral genetic material, 
is needed for the application of whole-genome sequencing in the field.    
In this study, 34 VNTR types were detected throughout the Midwestern United 
States, in which the VNTR types were predominately clustered by production flow versus 
state and year. However, a comparable sample size among Midwestern states and year 
was not evaluated, thus influencing the number of VNTR types detected and the potential 
diversity of M. hyopneumoniae. To provide further insight towards the molecular 
epidemiology of M. hyopneumoniae, a larger dataset that is composed of several samples 
collected throughout distinct geographical locations and over time is needed. In doing so, 
the temporal dynamics of circulating M. hyopneumoniae variants may be assessed, which 
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can help infer bacterial evolution and aid in the differentiation of unique or emerging 
variants.  
5.6 Conclusions 
In conclusion, differences in assay sensitivity and discriminatory power between 
the two molecular techniques were demonstrated, favoring the utilization of MLVA for 
the characterization of M. hyopneumoniae diversity compared to P146 sequencing. 
However, depending on the question at hand, the construction of phylogenetic trees using 
P146 sequencing can be utilized to help infer evolutionary relationships among M. 
hyopneumoniae variants. Further research focused on the utilization of whole-genome 
sequencing to further characterize M. hyopneumoniae is warranted, especially to identify 












Figure 5.1 Estimated probability of obtaining a complete result using Multiple-Locus 
Variable number tandem repeat Analysis (VNTR type) or P146 sequencing (sequence) 
based on Mycoplasma hyopneumoniae PCR Ct value  
Confidence intervals are depicted by shaded areas: gray (sequence); ivory (VNTR type). Gray dashed lines 





Figure 5.2 Minimum spanning tree for Mycoplasma hyopneumoniae Variable Number 
Tandem Repeat (VNTR) type obtained with Multiple-Locus Variable Number tandem 
repeat Analysis  
Circle size and color corresponds to sample size for each specific VNTR type, respectively. Numbers 
outside of each circle represent VNTR type for two loci, namely P97 and P146. Lines that connect circles 
depict relationship between VNTR types.  
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Table 5.1 Mean genetic distance as percentage difference in amino acids for Mycoplasma hyopneumoniae P146 field and reference 
sequences 
*=Mean genetic distance for all field sequences (n=120). Mhp=Mycoplasma hyopneumoniae. 
  
Field  
sequences   
Mhp_232 
USA   
Mhp_7448 
Brazil   
Mhp_BQ14 
France   
Mhp_168 
China   
Mhp_F7.2C 
Belgium   
Mhp_J 
Brazil 
Field sequences 2.9*             
Mhp_232_USA 3.2  ---           
Mhp_7448_Brazil 7.1  6.7  ---         
Mhp_BQ14_France 5.6  5.5  8.0  ---       
Mhp_168_China 6.5  6.2  7.4  6.9  ---     
Mhp_F7.2C_Belgium 7.6  7.1  6.6  8.5  7.1  ---   
Mhp_J_Brazil 2.8   3.3   6.2   5.2   6.1   7.0   --- 
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Table 5.2 Comparison of discriminatory power and congruence of assays for Mycoplasma hyopneumoniae molecular characterization 
Discriminatory power     
 MLVA loci     P146 sequencing 

















Assay congruency for RR3 P146 serine repeats   







    
      

















Figure 5.3 Maximum likelihood phylogenetic tree of Mycoplasma hyopneumoniae P146 
sequences  
Colors correspond to the number of serine repeats in P146-RR3. Phylogenetic tree was constructed using 
RAxML method with default settings for JTT-matrix model. Microreact was employed to illustrate the tree.  




Figure 5.4 Principal Coordinate Analysis (PCoA) plot illustrating clustering of Mycoplasma hyopneumoniae Variable Number 
Tandem Repeat (VNTR) type and P146 sequences by production flow  




Table 5.3 Variation in Variable Number Tandem Repeat (VNTR) type and genetic 
distance of P146 sequences based on epidemiological variables  
 VNTR type  P146 sequence 
 R2 p-value  R2 p-value 
Production flow 0.931 0.00  0.798 0.00 
Production stage 0.050 0.29  0.064 0.09 
State 0.126 0.00 
 
0.150 0.00 
Year 0.176 0.00  0.261 0.00 























Chapter 6: Genetic diversity of Mycoplasma hyopneumoniae within 
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The aim of this study was to assess the genetic variability of M. hyopneumoniae 
within various swine production flows. Four M. hyopneumoniae positive production 
flows, composed of four production stages, were selected for this study. Laryngeal and/or 
bronchial swabs were collected from each production stage within a flow, for a period of 
four months up to three years. Multiple-Locus Variable number tandem repeat Analysis 
(MLVA) was performed to assess the genetic variation of M. hyopneumoniae within and 
across production flows through the identification of Variable Number Tandem Repeat 
(VNTR) types. A maximum of six M. hyopneumoniae VNTR types were identified in a 
single flow, in which VNTR types appeared to be flow specific. An identical VNTR type 
was detected across several production stages for up to three years. In this study, minimal 
M. hyopneumoniae genetic variation was evidenced within and across production flows.  
6.2  Introduction  
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of 
enzootic pneumonia (EP) in swine (Maré and Switzer, 1965; Goodwin et al., 1965), a 
prevalent disease known to have a significantly negative impact in swine health and 
production worldwide (Pieters and Maes, 2019). Variability in M. hyopneumoniae 
virulence has been presumed due to demonstrated differences in clinical course (Vicca et 
al., 2002) and disease severity among strains (Vicca et al., 2003). Molecular 
characterization techniques have been developed and thus described genomic differences 
among strains (Betlach et al., 2019). Molecular findings have raised interest from 
veterinarians and researchers towards understanding the influence of M. hyopneumoniae 
variability on disease epidemiology. 
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Using Multiple-Locus Variable number tandem repeat Analysis (MLVA), studies 
have shown the presence of multiple M. hyopneumoniae Variable Number Tandem 
Repeat (VNTR) types at a geographic, production flow, herd, and individual pig level 
(Dos Santos et al., 2015; Rebaque et al., 2018; Pantoja et al., 2016; Michiels et al., 2017). 
However, the potential source of VNTR type variation has not been fully elucidated. 
Insight on understanding potential origins and drivers of genetic variation is critical for 
M. hyopneumoniae epidemiological investigations and to help tailor control strategies 
based on VNTR type(s) and diversity. Therefore, the aim of this study was to assess the 
genetic variability of M. hyopneumoniae within various swine production flows.  
6.3  Materials and methods 
6.3.1  Flow selection and background 
Four production flows (A-D) located in Central United States were selected based 
on positive status for M. hyopneumoniae, history of clinical signs suggestive of infection, 
and similar management protocols within one production system. In this study, a 
production flow was defined as a group of sites sharing pig sources and health status, and 
encompassed at least one herd from each production stage: gilt developing unit (GDU), 
sow herd, nursery, and finisher. All farms were single sourced by flow. Herds that 
belonged to each flow were located across different geographical states, except for flow 
A. The breeding stock source for all flows was presumed M. hyopneumoniae negative gilt 
multipliers that originated within the production system, and their health status was 
confirmed through routine diagnostics. Upon arrival into the breeding herd, gilts were 
acclimated through a seeder-to-naïve model by introducing M. hyopneumoniae positive 
culled sows and gilts into flow specific GDUs. Gilt acclimation strategies were utilized in 
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the GDUs to help to promote M. hyopneumoniae stability within the sow herd. Gilts were 
vaccinated with a commercial M. hyopneumoniae bacterin at arrival into the sow herds. 
Moreover, all suckling pigs in each flow received a dose of commercial M. 
hyopneumoniae bacterin at three weeks of age. Pigs were humanely cared for and 
adequate housing and nutritional demands were met or exceeded. All health and welfare 
standards were approved by the attending veterinarian(s).   
6.3.2  Study design 
A total of 262 samples, consisting of either laryngeal or bronchial swabs, were 
collected from the four production flows. In each flow, swabs were obtained from 1-4 
herds per production stage (i.e., GDU, sow herd, nursery, and finisher) for a period of 
four months up to three years. Flow sample sizes were estimated to detect at least one 
test-positive individual in the sample with a group sensitivity of 95%.  Thus, at least one 
VNTR type per production stage for each flow was estimated to be detected. Laryngeal 
swabs were obtained from pigs expressing clinical signs suggestive of M. hyopneumoniae 
infection. In the case that clinical signs were not observed, pigs to be sampled were 
randomly selected from the population. Bronchial swabs were collected if mortalities 
were observed.  
6.3.3  Sample collection and processing  
Laryngeal and bronchial swabs were collected using a sterile collection swab 
(BBLTM CultureSwabTM, Becton, Dickinson and Company, Sparks, MD, USA) as 
previously described (Sievers et al., 2015; Pieters et al., 2017). Samples were refrigerated 
immediately after collection and were stored at approximately -20oC until processed.  
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DNA extraction (MagMAXTM96 Viral RNA Isolation Kit and MagMAXTM 
Express96 Magnetic Particle Processor, Life Technologies, Grand Island, NY, USA) and 
species-specific M. hyopneumoniae real-time PCR (VetMAXTM qPCR Master Mix and 
VetMAXTM M. hypopneumoniae Reagents Kit, Life Technologies, Grand Island, NY, 
USA) were performed at the University of Minnesota Veterinary Diagnostic Laboratory. 
Samples with a Ct value ≤37 were considered positive for M. hyopneumoniae and those 
with a Ct value ≤32 were selected for genetic typing (Dos Santos, personal 
communication). To assess the genetic variability of M. hyopneumoniae, VNTR typing 
was performed as described (Dos Santos et al., 2015). The Mycoplasma hyopneumoniae 
ATCC 25095 reference strain and molecular grade water were used as a positive and 
negative control.   
6.3.4  Data analysis  
Results were analyzed using a bioinformatics analytic software (BioNumerics, 
version 7.1, Applied Maths, Austin, TX, USA) according to the parameters described by 
Dos Santos et al. (2015). A minimum spanning tree (MST) was created to illustrate the 
relationship between VNTR types within and across flows.  
6.4 Results 
Overall, 45.4% (119/262) samples were positive for M. hyopneumoniae by real-
time PCR. Within two flows (B and D), a higher proportion of bronchial swabs (100-
88.9%) were positive compared to laryngeal swabs (55.5-46.7%). A VNTR type was 
obtained in 83.6% (41/49) of the samples in which MLVA was attempted. A graphic 
representation of VNTR types from all flows over time is presented in Figure 6.1. Across 
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the four flows, a total of 15 VNTR types were identified, in which a single flow consisted 
of 1-6 VNTR types. During a single sampling event, up to three VNTR types were 
identified within a herd. A dominant type (i.e., 16-24, 9-12, 11-21, 13-17) was observed 
in flows A-D, respectively (Figure 6.1). In flows A, B, and C an identical VNTR type 
was identified in the GDU and grower sites (i.e., nursery or finisher) from four months up 
to two years (Figure 2). In addition, an identical VNTR type was identified in two 
finishers in flow D, for approximately two years (Figure 6.2). Based on sample type, an 
identical VNTR type (9-12 and 11-22) was detected in laryngeal and bronchial swabs for 
flows B and C, respectively. In flow D, two VNTR types (14-18 and 13-19) were only 
identified in bronchial swabs.   
6.5 Discussion 
In this study, 3-6 VNTR types were identified in three of the four flows, in which 
the predominant type(s) varied by 1-3 tandem repeats. Previous literature has shown the 
detection of multiple M. hyopneumoniae VNTR types in a site and group of pigs (Pantoja 
et al., 2016; Michiels et al., 2017). Moreover, the number and diversity of VNTR types 
present in a herd may be potential factors towards disease outcome as recent work has 
shown that lung severity may be influenced by the existence of more than one VNTR 
type in a herd (Vranckx et al., 2011; Michiels et al., 2017). However, the etiologic cause 
and importance of genomic modifications evidenced in VNTR length differences by 
MLVA typing has not been fully described. Since these flows were similarly managed, 
the potential impact of swine management and control methods, namely co-sourcing 
flows and different vaccine and antimicrobial programs, on M. hyopneumoniae genetic 
137 
 
variation could not be investigated. Therefore, further information is needed on this topic 
to help explore potential drivers of genetic diversity.   
An identical VNTR type was identified over several years and production stages 
within a flow, which is comparable to results of Rebaque et al. (2018). In each flow, the 
VNTR types identified in nursery and finisher herds appeared to be derived from the 
breeding herds (i.e., GDU and sow herds), in which those pigs were sourced from. This 
statement is further supported by the detection of flow specific types, since a common 
VNTR type was not detected between flows. In endemic populations, the circulation of 
M. hyopneumoniae in swine production flows has been thought to originate from 
incoming gilts and shedding sows through dam-to-piglet transmission (Fano et al., 2007; 
Maes et al., 2018). Lateral transmission of this microorganism has been suggested to 
occur at long distances (Goodwin, 1985; Otake et al., 2010). However, recent field data 
proposes that the likelihood of M. hyopneumoniae lateral transmission in high density 
swine populations may be minimal (Yeske, 2017). With this knowledge, the origin of M. 
hyopneumoniae infection and VNTR type in grower-finisher sites appeared to be 
dependent on the sourcing herd regardless of sampling time. Such information is 
important to consider when structuring management of flows and M. hyopneumoniae 
control and acclimation strategies.  
6.6 Conclusions 
In conclusion, M. hyopneumoniae genetic variability within swine flows was 
minimal over time and flow specific under the conditions of this study. The circulation of 
existing M. hyopneumoniae VNTR types appeared to be derived from breeding herds, 
potentially through dam-to-piglet transmission. Further research focused on determining 
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the effect of different management strategies (e.g., vaccination, antimicrobials) and 
geographical location on M. hyopneumoniae genetic variability should be implemented to 









Figure 6.1 Minimum spanning tree of Mycoplasma hyopneumoniae Variable Number 
Tandem Repeat (VNTR) types 
     =Flow A.     =Flow B.     =Flow C.      =Flow D. 
Grey shading illustrates clonal complex of VNTR types. The lines connecting two circles show a 
relationship between the VNTR types, whereas the darker lines represent a clonal complex. The two 
numbers outside of each circle correspond to the VNTR type in the sample. Each number represents the 
number of tandem repeats for P97 and P146 loci, respectively. Circle size corresponds to sample size (the 
larger the circle, the more samples with the specific VNTR type). For example, n=1, 2, 4, and 15 for VNTR 





Figure 6.2 Mycoplasma hyopneumoniae Variable Number Tandem Repeat (VNTR) 
types identified over time by flow and production stage 
     =Gilt developing unit.     =Sow herd.      =Nursery.      =Finisher. 
Each box corresponds to a production flow (A-D). Each circle represents a single VNTR type detected at a 
given herd and date. Within each circle, the first and second number correspond to the number of tandem 


























  In the literature, ‘disease control’ has been defined as the reduction in incidence, 
prevalence, morbidity, or mortality of an infectious disease to a locally acceptable level, 
whereas ‘elimination’ is often defined as the absence of disease or infection incidence 
caused by a specific pathogen in a localized geographical area (Dowdle, 1998). It is 
important to note that disease control and elimination result from deliberate efforts that 
halt pathogen transmission. Furthermore, continued measures to either maintain a 
reduced level of infection and/or disease, or prevent re-establishment of transmission are 
required. Principles in achieving disease control and elimination include: 1) practical 
diagnostic tools with sufficient sensitivity and specificity to detect infection levels that 
can lead to transmission; 2) effective intervention(s) to interrupt transmission of an agent; 
3) resources to trace and monitor pathogen spread; and 4) confirmation of pathogen 
absence in the population (Miller et al., 2006).  
Over the past decade, there has been an increased interest to procure and maintain 
M. hyopneumoniae negative herds, due to the growing awareness of the detrimental and 
long-term effects that enzootic pneumonia has on pig health and productivity. Moreover, 
significant economic losses attributed to M. hyopneumoniae have been calculated in 
affected herds, thus demonstrating the value of freedom of disease. Even after the 
combined use of several preventive or treatment interventions, in many cases only partial 
disease control is achieved. Therefore, M. hyopneumoniae elimination is considered the 
only option for total disease control. In the field, the elimination of M. hyopneumoniae, 
followed by a short return of investment has been described, which makes this control 
method even more appealing to producers and veterinarians. However, there are several 
cases in which the continuation or occurrence of M. hyopneumoniae infection or disease 
143 
 
has been described, thus questioning the efficacy of control, elimination, and prevention 
strategies, as well as pathogen origin.  
For M. hyopneumoniae, current knowledge of pathogen transmissibility has 
stemmed from studies under experimental conditions that have traditionally used clinical 
samples of low or medium diagnostic sensitivity. Therefore, the ability to accurately 
detect and predict pathogen spread may be difficult to extrapolate to field conditions. 
Chapter 2 of this thesis evaluated the natural transmission and detection of M. 
hyopneumoniae based on the introduction of one infected gilt to a naïve population. The 
ability to detect a recent M. hyopneumoniae introduction using clinical samples of high 
diagnostic sensitivity was also explored. From this study, the slow transmission of M. 
hyopneumoniae was evident, as infections derived from the index case were initially 
detected six weeks after introducing the infected pig. Moreover, the study’s findings shed 
light on the potential false diagnostic assurance that can result from currently employed 
surveillance protocols for M. hyopneumoniae. It is important to mention that differences 
in pathogenicity and virulence have been described across M. hyopneumoniae strains, 
which can influence infection dynamics and transmissibility. Information generated in 
Chapter 2 can be used to design accurate surveillance protocols that are specifically 
tailored for M. hyopneumoniae in replacement gilt populations, along with the potential 
modification of gilt isolation procedures. During the development of surveillance 
protocols, a budget analysis with the inclusion of sample pooling to aid in feasibility and 
practicality should be conducted, as well as a long-term benefit-cost analysis that 
considers the economics attributed to disease prevention versus the cost of undergoing 
disease elimination. Secondly, transmission parameters that were calculated in Chapter 2 
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can be incorporated into future epidemiological models to either 1) provide insight 
retrospectively for the presumed onset of M. hyopneumoniae introduction in outbreak 
scenarios based on pathogen prevalence and timing of clinical disease in the herd or 2) be 
utilized as a prior for M. hyopneumoniae transmission in disease modeling.  
Understanding the efficacy of interventions to slow or stop pathogen transmission 
is vital for optimizing M. hyopneumoniae control and elimination strategies. Despite their 
wide use, there is limited information on whether vaccinations and medication can reduce 
pathogen spread. In Chapter 3, the employment of multiple vaccinations on M. 
hyopneumoniae transmission was evaluated using an in-vivo seeder-to-contact challenge 
model. Results suggested that a three-dose vaccination strategy against M. 
hyopneumoniae numerically reduced the transmission of this microorganism, favoring 
conditions when both seeders and their corresponding contact gilts were vaccinated. 
Moreover, Chapter 4 explored the effect of a bacteriostatic antibiotic treatment on the 
infectious potential of M. hyopneumoniae during different phases of infection. In the 
fourth chapter, the administration of antibiotics during the acute phase of infection 
numerically reduced the rate of secondary M. hyopneumoniae infections. However, the 
role of medication on M. hyopneumoniae transmission could not be assessed during the 
chronic phase of infection. Interestingly, the persistence of M. hyopneumoniae genetic 
material detected by PCR was shown by the lack of clearance in most treated and 
chronically infected gilts, which lasted for up to three months, which was the last time 
when it was evaluated. Since the infectious potential of M. hyopneumoniae could not be 
inferred during the chronic phase of infection, research that investigates drivers of 
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pathogen persistence, as well as alternative methods to assess pathogen viability post-
medication is needed.  
The field application of results from Chapters 3 and 4 would be most beneficial 
for disease elimination efforts in endemically infected herds or outbreak scenarios. For 
M. hyopneumoniae elimination strategies, sow herds are either vaccinated once or 
quarterly during whole herd medication, or herd closure and medication programs, 
respectively. Furthermore, antibiotics are often administered during the last seven to four 
weeks of a 34-week extended herd closure and medication program. Based on the 
findings in Chapters 3 and 4, incorporating a multi-dose vaccination strategy or 
medication during the early stages of an elimination program warrants investigation, as 
the timing of these control interventions may influence pathogen transmissibility, 
resulting in potential differences in the success of elimination programs.   
 Another research area of interest is the effect of vaccination and medication 
timing on M. hyopneumoniae disease control and transmission during disease outbreaks. 
Currently, there is minimal information on this topic, and veterinarians often question 
which control measures should be employed and their frequency of application. 
Throughout the literature, several vaccination strategies, which vary based on the number 
or frequency of vaccinations or bacterin applications, have been explored, in which 
complete protection is not achieved. However, the role of vaccination timing on immune 
induction and whether this may aid in the reduction of pathogen spread has not been 
previously investigated. To provide insight on this topic, information generated in 
Chapters 3 and 4 can be incorporated into epidemiological models to simulate and 
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compare potential differences in the spread of M. hyopneumoniae based on medication 
and vaccination timing.   
For the last two chapters of this dissertation, insight into the molecular 
epidemiology of M. hyopneumoniae was gained. In Chapter 5, two different molecular 
techniques, namely MLVA and P146 sequencing, were compared in a parallel manner to 
characterize circulating M. hyopneumoniae variants in the Midwestern United States. 
Findings from this study highlighted slight differences in assay sensitivity and 
discriminatory power between the two molecular techniques. Nevertheless, both 
techniques showed wide genetic diversity among M. hyopneumoniae variants, and similar 
epidemiological inferences were obtained from the two assays, as production flow 
explained most of the variation in the clustering of VNTR types and P146 sequences. 
One question that remains unanswered is the classification of M. hyopneumoniae variants 
and the biological importance of such genetic variability. Additional work utilizing 
whole-genome sequencing should be conducted to evaluate the presence of other variable 
areas within the genome that are unrepresented by MLVA and P146 sequencing. For 
other bacterial pathogens, whole-genome sequencing is commonly employed, largely due 
to feasibility in bacterial culture. Given the restrictions with M. hyopneumoniae isolation, 
development of procedures to optimize sample quality for whole-genome sequencing 
using clinical samples is warranted. Moreover, an ongoing database for M. 
hyopneumoniae VNTR types and/or sequences should be established, such that 
knowledge regarding the temporality of M. hyopneumoniae variants and potential 
bacterial evolution can be discovered. Based on the findings from Chapter 5, the genetic 
diversity of M. hyopneumoniae across swine production flows was evaluated in Chapter 
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6. From Chapter 6, insight for pathogen origin in downstream herds was provided based 
on the presence of a common M. hyopneumoniae variant that was shared between 
finishers and the sourcing herds (i.e., sow herds). Therefore, the findings from Chapter 6 
showed how molecular characterization techniques could be applied in the field to help 
link pathogen transmission between herds.  
  This dissertation addressed several questions surrounding the detection, control, 
and molecular characterization of M. hyopneumoniae. The research conducted generated 
new information that can be readily applied in the field to aid pathogen surveillance, 
control, and elimination efforts.  
The work presented in this dissertation also highlighted several areas that would 
benefit from further research such as:  
• Development and economic analysis of surveillance protocols for M. 
hyopneumoniae detection in replacement gilt populations. Based on the 
knowledge generated in this thesis, surveillance protocols should include 
the collection of lower respiratory tract samples types. These protocols 
should consider different sample types, diagnostic tests, sample sizes, 
sample frequencies, and isolation length.  
 
• Further evaluation of M. hyopneumoniae transmission using antibiotics 
with differing modes of action and application timing. To answer this 
topic, a simulation model would have to be developed based on data 
generated from in-vivo challenge models that evaluate differences in 
148 
 
transmission parameters, such as adjusted reproductive number.  
 
• Efficacy of M. hyopneumoniae elimination based on strategies that vary 
based on timing of whole herd medication and/or vaccination. To answer 
this question, prospective quasi-experiments can be conducted, in which 
reduction in prevalence or incidence can be measured post-intervention 
followed by differences in length of closure based on employed strategy.  
  
• Development of diagnostic techniques to assess pathogen viability post-
antibiotic treatment. Alternative methods to evaluate pathogen viability 
from antemortem samples should be developed, considering limitations 
with using in-vivo models and the slow transmission of M. 
hyopneumoniae.  
 
• Further evaluation of M. hyopneumoniae characterization using whole 
genome sequencing, along with the potential drivers for M. 
hyopneumoniae genetic diversity  
In summary, an overall review of the results of this thesis was presented in this 
section, along with the most important implications for field applications and research 
questions derived from the newly generated information. In addition, future research 
directions were listed, which can represent the starting point of continued investigations 
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Supplementary files for Chapter 3 
Table S1. Diagnostic results for Mycoplasma hyopneumoniae detection and seroconversion   
Pig ID Treatment 
Dpi   -42 -28 -14 0 28 35 42 
Dpc  -70 -56 -42  0 7 14 
Assay ELISA ELISA ELISA PCR ELISA PCR ELISA PCR ELISA PCR PCR* ELISA 
1 NVS  71.52 83.61 88.71 - 92.86 25.34 41.37 23.60 19.42 33.59 29.22 25.65 
2 NVC  90.49 79.45 99.14   - 98.88 - 82.24 - - 85.30 
3 NVS  85.66 90.87 84.83 - 95.51 24.10 54.56 26.66 22.42 25.01 25.09 23.99 
4 NVC  83.06 85.55 86.33   - 93.63 - 92.71 - - 85.25 
5 NVS  63.10 87.33 89.53 - 97.39 30.91 30.63 27.62 30.63 33.35 26.91 14.67 
6 NVC  67.70 83.33 94.28   - 90.14 - 90.20 33.15 29.49 92.64 
7 NVS  81.67 91.48 91.04 - 95.90 26.59 42.99 26.35 32.98 28.25 29.32 39.30 
8 NVC  80.45 91.82 86.33   - 103.99 - 79.37 - - 92.45 
9 VS  76.13 52.84 15.34 - 9.26 20.88 1.29 33.54 1.74 34.28 26.31 1.91 
10 NVC  88.66 73.69 93.42   - 87.22 - 97.26 - - 94.49 
11 VS  87.33 62.66 24.74 - 13.46 22.99 1.16 25.13 1.29 - 24.75 101.26 
12 NVC  92.48 85.28 88.66   - 113.58 - 89.13 23.45 36.52 1.72 
13 VS  83.39 82.78 14.57 - 4.40 - 8.22 - 13.21 - 38.20 25.49 
14 NVC  72.47 72.35 84.05   - 87.74 - 92.66 - 38.01 103.04 
15 VS  75.07 71.08 N/A - 18.71 - 30.24 - 46.56 31.06 39.99 63.16 
16 NVC  97.36 80.73 78.07   - 94.22 - 92.83 - - 97.30 
17 NVS  82.28 96.14 89.82 - 99.53 23.32 45.91 29.69 41.50 29.59 23.17 46.51 
18 VC  96.37 52.82 14.18   - 14.89 - 17.93 - - 29.73 
19 NVS  87.27 83.84 84.55 - 96.22 20.52 22.21 26.65 19.68 26.83 31.40 21.24 
20 VC  82.56 70.19 31.27   - 32.13 - 29.72 - - 58.89 
21 NVS  103.24 84.55 79.84 - 96.09 29.76 30.69 33.60 32.44 33.69 31.92 33.69 
22 VC  76.85 75.29 20.39   - 41.12 - 40.73 - - 64.89 
23 NVS  86.49 82.06 87.88 - 98.55 28.85 45.00 25.45 34.83 30.09 25.57 42.36 
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Treatment: VS (Vaccinated seeder); NVS (Non-vaccinated seeder); VC (Vaccinated contact); NVC (Non-vaccinated contact). Dpi=days post-inoculation. 
Dpc=days post-contact. Positive results are bolded. Negative PCR results are indicated as (-). PCR*=Detection in bronchial swabs. ELISA results are expressed 
as percent inhibition and interpretated as positive for values ≤50 and negative for values >50. PCR results are expressed as Ct values and interpreted as positive 
for values <40.  
 
 
24 VC  79.18 60.94 31.53   - 13.59 37.18 23.32 33.32 35.13 38.47 
25 VS  97.25 74.18 17.93 - 2.84 30.39 3.95 32.87 5.05 34.29 21.45 6.63 
26 VC  72.69 66.14 25.38   - 27.26 - 40.06 - - 41.02 
27 VS  110.62 51.28 15.28 - N/A 29.56 1.94 32.03 2.52 34.34 29.17 4.75 
28 VC  59.82 75.74 30.04   - 49.66 - 55.83 - - 72.16 
29 VS  72.07 86.38 44.09 - N/A 23.58 2.72 28.27 3.23 27.44 25.60 3.57 
30 VC  71.30 66.98 24.74   - 14.44 - 23.67 - - 45.36 
31 VS  75.68 80.95 33.15 - 7.64 30.39 3.69 33.82 4.72 38.40 28.68 8.55 
32 VC  100.91 69.58 13.10   - 10.94 - 23.83 - - 22.71 
